Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1994 Oct;7(4):505–532. doi: 10.1128/cmr.7.4.505

Hepatitis C: progress and problems.

J A Cuthbert 1
PMCID: PMC358339  PMID: 7834603

Abstract

The hepatitis C virus (HCV), a single-stranded RNA virus, is the major cause of posttransfusion hepatitis. HCV isolates differ in nucleotide and amino acid sequences. Nucleotide changes are concentrated in hypervariable regions and may be related to immune selection. In most immunocompetent persons, HCV infection is diagnosed serologically, using antigens from conserved regions. Amplification of RNA may be necessary to detect infection in immunosuppressed patients. Transmission by known parenteral routes is frequent; other means of spread are less common and may represent inapparent, percutaneous dissemination. Infection can lead to classical acute hepatitis, but most infected persons have no history of acute disease. Once infected, most individuals apparently remain carriers of the virus, with varying degrees of hepatocyte damage and fibrosis ensuing. Chronic hepatitis may lead to cirrhosis and hepatocellular carcinoma. However, disease progression varies widely, from less than 2 years to cirrhosis in some patients to more than 30 years with only chronic hepatitis in others. Determinants important in deciding outcome are unknown. Alpha interferon, which results in sustained remission in selected patients, is the only available therapy. Long-term benefits from such therapy have not been demonstrated. Prevention of HCV infection by vaccination is likely to be challenging if ongoing viral mutation results in escape from neutralization and clearance.

Full text

PDF
506

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aach R. D., Stevens C. E., Hollinger F. B., Mosley J. W., Peterson D. A., Taylor P. E., Johnson R. G., Barbosa L. H., Nemo G. J. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med. 1991 Nov 7;325(19):1325–1329. doi: 10.1056/NEJM199111073251901. [DOI] [PubMed] [Google Scholar]
  2. Abe K., Inchauspe G., Shikata T., Prince A. M. Three different patterns of hepatitis C virus infection in chimpanzees. Hepatology. 1992 Apr;15(4):690–695. doi: 10.1002/hep.1840150423. [DOI] [PubMed] [Google Scholar]
  3. Agnello V., Chung R. T., Kaplan L. M. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992 Nov 19;327(21):1490–1495. doi: 10.1056/NEJM199211193272104. [DOI] [PubMed] [Google Scholar]
  4. Akahane Y., Kojima M., Sugai Y., Sakamoto M., Miyazaki Y., Tanaka T., Tsuda F., Mishiro S., Okamoto H., Miyakawa Y. Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med. 1994 May 1;120(9):748–752. doi: 10.7326/0003-4819-120-9-199405010-00005. [DOI] [PubMed] [Google Scholar]
  5. Akatsuka T., Donets M., Scaglione L., Ching W. M., Shih J. W., Di Bisceglie A. M., Feinstone S. M. B-cell epitopes on the hepatitis C virus nucleocapsid protein determined by human monospecific antibodies. Hepatology. 1993 Sep;18(3):503–510. [PubMed] [Google Scholar]
  6. Alberti A., Chemello L., Bonetti P., Casarin C., Diodati G., Cavalletto L., Cavalletto D., Frezza M., Donada C., Belussi F. Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C. The TVVH Study Group. J Hepatol. 1993;17 (Suppl 3):S123–S126. doi: 10.1016/s0168-8278(05)80436-2. [DOI] [PubMed] [Google Scholar]
  7. Allain J. P., Coghlan P. J., Kenrick K. G., Whitson K., Keller A., Cooper G. J., Vallari D. S., Delaney S. R., Kuhns M. C. Prediction of hepatitis C virus infectivity in seropositive Australian blood donors by supplemental immunoassays and detection of viral RNA. Blood. 1991 Nov 1;78(9):2462–2468. [PubMed] [Google Scholar]
  8. Alter H. J., Purcell R. H., Shih J. W., Melpolder J. C., Houghton M., Choo Q. L., Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med. 1989 Nov 30;321(22):1494–1500. doi: 10.1056/NEJM198911303212202. [DOI] [PubMed] [Google Scholar]
  9. Alter M. J., Coleman P. J., Alexander W. J., Kramer E., Miller J. K., Mandel E., Hadler S. C., Margolis H. S. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA. 1989 Sep 1;262(9):1201–1205. [PubMed] [Google Scholar]
  10. Alter M. J., Hadler S. C., Judson F. N., Mares A., Alexander W. J., Hu P. Y., Miller J. K., Moyer L. A., Fields H. A., Bradley D. W. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA. 1990 Nov 7;264(17):2231–2235. [PubMed] [Google Scholar]
  11. Alter M. J., Margolis H. S., Krawczynski K., Judson F. N., Mares A., Alexander W. J., Hu P. Y., Miller J. K., Gerber M. A., Sampliner R. E. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med. 1992 Dec 31;327(27):1899–1905. doi: 10.1056/NEJM199212313272702. [DOI] [PubMed] [Google Scholar]
  12. Atrah H. I., Ala F. A., Gough D. Blood exchanged in ritual ceremonies as a possible route for infection with hepatitis C virus. J Clin Pathol. 1994 Jan;47(1):87–87. doi: 10.1136/jcp.47.1.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bach N., Thung S. N., Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology. 1992 Apr;15(4):572–577. doi: 10.1002/hep.1840150403. [DOI] [PubMed] [Google Scholar]
  14. Balart L. A., Perrillo R., Roddenberry J., Regenstein F., Shim K. S., Shieh Y. S., Taylor B., Dash S., Gerber M. A. Hepatitis C RNA in liver of chronic hepatitis C patients before and after interferon alfa treatment. Gastroenterology. 1993 May;104(5):1472–1477. doi: 10.1016/0016-5085(93)90358-j. [DOI] [PubMed] [Google Scholar]
  15. Barrera J. M., Bruguera M., Ercilla M. G., Sánchez-Tapias J. M., Gil M. P., Costa J., Gelabert A., Rodés J., Castillo R. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers. Ann Intern Med. 1991 Oct 15;115(8):596–600. doi: 10.7326/0003-4819-115-8-596. [DOI] [PubMed] [Google Scholar]
  16. Beach M. J., Meeks E. L., Mimms L. T., Vallari D., DuCharme L., Spelbring J., Taskar S., Schleicher J. B., Krawczynski K., Bradley D. W. Temporal relationships of hepatitis C virus RNA and antibody responses following experimental infection of chimpanzees. J Med Virol. 1992 Mar;36(3):226–237. doi: 10.1002/jmv.1890360314. [DOI] [PubMed] [Google Scholar]
  17. Beloqui O., Prieto J., Suárez M., Gil B., Qian C. H., García N., Civeira M. P. N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study. J Interferon Res. 1993 Aug;13(4):279–282. doi: 10.1089/jir.1993.13.279. [DOI] [PubMed] [Google Scholar]
  18. Bertolini E., Battezzati P. M., Zermiani P., Bruno S., Moroni G. A., Marelli F., Villa E., Manenti F., Zuin M., Crosignani A. Hepatitis C virus testing in primary biliary cirrhosis. J Hepatol. 1992 May;15(1-2):207–210. doi: 10.1016/0168-8278(92)90037-p. [DOI] [PubMed] [Google Scholar]
  19. Biswas R. M., Nedjar S., Wilson L. T., Mitchell F. D., Snoy P. J., Finlayson J. S., Tankersley D. L. The effect on the safety of intravenous immunoglobulin of testing plasma for antibody to hepatitis C. Transfusion. 1994 Feb;34(2):100–104. doi: 10.1046/j.1537-2995.1994.34294143934.x. [DOI] [PubMed] [Google Scholar]
  20. Björkander J., Cunningham-Rundles C., Lundin P., Olsson R., Söderström R., Hanson L. A. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med. 1988 Jan;84(1):107–111. doi: 10.1016/0002-9343(88)90016-2. [DOI] [PubMed] [Google Scholar]
  21. Blajchman M. A., Feinman S. V., Bull S. B. The incidence of post-transfusion hepatitis. N Engl J Med. 1993 Apr 29;328(17):1280–1281. doi: 10.1056/NEJM199304293281716. [DOI] [PubMed] [Google Scholar]
  22. Blight K., Rowland R., Hall P. D., Lesniewski R. R., Trowbridge R., LaBrooy J. T., Gowans E. J. Immunohistochemical detection of the NS4 antigen of hepatitis C virus and its relation to histopathology. Am J Pathol. 1993 Dec;143(6):1568–1573. [PMC free article] [PubMed] [Google Scholar]
  23. Bohman V. R., Stettler R. W., Little B. B., Wendel G. D., Sutor L. J., Cunningham F. G. Seroprevalence and risk factors for hepatitis C virus antibody in pregnant women. Obstet Gynecol. 1992 Oct;80(4):609–613. [PubMed] [Google Scholar]
  24. Bouffard P., Hayashi P. H., Acevedo R., Levy N., Zeldis J. B. Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. J Infect Dis. 1992 Dec;166(6):1276–1280. doi: 10.1093/infdis/166.6.1276. [DOI] [PubMed] [Google Scholar]
  25. Brackmann S. A., Gerritzen A., Oldenburg J., Brackmann H. H., Schneweis K. E. Search for intrafamilial transmission of hepatitis C virus in hemophilia patients. Blood. 1993 Feb 15;81(4):1077–1082. [PubMed] [Google Scholar]
  26. Bradley D. W., Maynard J. E., Popper H., Cook E. H., Ebert J. W., McCaustland K. A., Schable C. A., Fields H. A. Posttransfusion non-A, non-B hepatitis: physicochemical properties of two distinct agents. J Infect Dis. 1983 Aug;148(2):254–265. doi: 10.1093/infdis/148.2.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Bresters D., Cuypers H. T., Reesink H. W., Chamuleau R. A., Schipper M. E., Boeser-Nunnink B. D., Lelie P. N., Jansen P. L. Detection of hepatitis C viral RNA sequences in fresh and paraffin-embedded liver biopsy specimens of non-A, non-B hepatitis patients. J Hepatol. 1992 Jul;15(3):391–395. doi: 10.1016/0168-8278(92)90075-z. [DOI] [PubMed] [Google Scholar]
  28. Bresters D., Cuypers H. T., Reesink H. W., Schaasberg W. P., van der Poel C. L., Mauser-Bunschoten E. P., Houghton M., Choo Q. L., Kuo G., Lesniewski R. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus. Vox Sang. 1992;62(4):213–217. doi: 10.1111/j.1423-0410.1992.tb01201.x. [DOI] [PubMed] [Google Scholar]
  29. Bresters D., Mauser-Bunschoten E. P., Reesink H. W., Roosendaal G., van der Poel C. L., Chamuleau R. A., Jansen P. L., Weegink C. J., Cuypers H. T., Lelie P. N. Sexual transmission of hepatitis C virus. Lancet. 1993 Jul 24;342(8865):210–211. doi: 10.1016/0140-6736(93)92300-i. [DOI] [PubMed] [Google Scholar]
  30. Bresters D., Zaaijer H. L., Cuypers H. T., Reesink H. W., Winkel I. N., van Exel-Oehlers P. J., van Drimmelen A. A., Jansen P. L., van der Poel C. L., Lelie P. N. Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients. Transfusion. 1993 Aug;33(8):634–638. doi: 10.1046/j.1537-2995.1993.33893342743.x. [DOI] [PubMed] [Google Scholar]
  31. Brettler D. B., Alter H. J., Dienstag J. L., Forsberg A. D., Levine P. H. Prevalence of hepatitis C virus antibody in a cohort of hemophilia patients. Blood. 1990 Jul 1;76(1):254–256. [PubMed] [Google Scholar]
  32. Brillanti S., Garson J. A., Tuke P. W., Ring C., Briggs M., Masci C., Miglioli M., Barbara L., Tedder R. S. Effect of alpha-interferon therapy on hepatitis C viraemia in community-acquired chronic non-A, non-B hepatitis: a quantitative polymerase chain reaction study. J Med Virol. 1991 Jun;34(2):136–141. doi: 10.1002/jmv.1890340213. [DOI] [PubMed] [Google Scholar]
  33. Brown D., Powell L., Morris A., Rassam S., Sherlock S., McIntyre N., Zuckerman A. J., Dusheiko G. M. Improved diagnosis of chronic hepatitis C virus infection by detection of antibody to multiple epitopes: confirmation by antibody to synthetic oligopeptides. J Med Virol. 1992 Nov;38(3):167–171. doi: 10.1002/jmv.1890380303. [DOI] [PubMed] [Google Scholar]
  34. Bréchot C., Kremsdorf D. Genetic variation of the hepatitis C virus (HCV) genome: random events or a clinically relevant issue? J Hepatol. 1993 Mar;17(3):265–268. doi: 10.1016/s0168-8278(05)80203-x. [DOI] [PubMed] [Google Scholar]
  35. Bukh J., Purcell R. H., Miller R. H. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8234–8238. doi: 10.1073/pnas.90.17.8234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Bukh J., Purcell R. H., Miller R. H. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):187–191. doi: 10.1073/pnas.89.1.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Bukh J., Purcell R. H., Miller R. H. Sequence analysis of the 5' noncoding region of hepatitis C virus. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4942–4946. doi: 10.1073/pnas.89.11.4942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Bukh J., Wantzin P., Krogsgaard K., Knudsen F., Purcell R. H., Miller R. H. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group. J Infect Dis. 1993 Dec;168(6):1343–1348. doi: 10.1093/infdis/168.6.1343. [DOI] [PubMed] [Google Scholar]
  39. Buscarini E., Tanzi E., Zanetti A. R., Savi E., Sbolli G., Civardi G., Di Stasi M., Fornari F., Buscarini L. High prevalence of antibodies to hepatitis C virus among family members of patients with anti-HCV-positive chronic liver disease. Scand J Gastroenterol. 1993 Apr;28(4):343–346. doi: 10.3109/00365529309090253. [DOI] [PubMed] [Google Scholar]
  40. Callahan J. D., Constantine N. T., Kataaha P., Zhang X., Hyams K. C., Bansal J. Second generation hepatitis C virus assays: performance when testing African sera. J Med Virol. 1993 Sep;41(1):35–38. doi: 10.1002/jmv.1890410108. [DOI] [PubMed] [Google Scholar]
  41. Camps J., Crisóstomo S., García-Granero M., Riezu-Boj J. I., Civeira M. P., Prieto J. Prediction of the response of chronic hepatitis C to interferon alfa: a statistical analysis of pretreatment variables. Gut. 1993 Dec;34(12):1714–1717. doi: 10.1136/gut.34.12.1714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Cassani F., Muratori L., Manotti P., Lenzi M., Fusconi M., Ballardini G., Selleri L., Volta U., Zauli D., Miniero R. Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection. Gut. 1992 Sep;33(9):1260–1263. doi: 10.1136/gut.33.9.1260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Cha T. A., Kolberg J., Irvine B., Stempien M., Beall E., Yano M., Choo Q. L., Houghton M., Kuo G., Han J. H. Use of a signature nucleotide sequence of hepatitis C virus for detection of viral RNA in human serum and plasma. J Clin Microbiol. 1991 Nov;29(11):2528–2534. doi: 10.1128/jcm.29.11.2528-2534.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Chamot E., Hirschel B., Wintsch J., Robert C. F., Gabriel V., Déglon J. J., Yerly S., Perrin L. Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users. AIDS. 1990 Dec;4(12):1275–1277. doi: 10.1097/00002030-199012000-00016. [DOI] [PubMed] [Google Scholar]
  45. Chan T. M., Lok A. S., Cheng I. K., Chan R. T. A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology. 1993 Mar;104(3):862–868. doi: 10.1016/0016-5085(93)91023-b. [DOI] [PubMed] [Google Scholar]
  46. Chan T. M., Lok A. S., Cheng I. K., Chan R. T. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. Hepatology. 1993 Jan;17(1):5–8. [PubMed] [Google Scholar]
  47. Chang T. T., Liou T. C., Young K. C., Lin X. Z., Lin C. Y., Shin J. S., Wu H. L. Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission. J Med Virol. 1994 Jan;42(1):91–96. doi: 10.1002/jmv.1890420117. [DOI] [PubMed] [Google Scholar]
  48. Chaudhary R. K., Perry E., Hicks F., MacLean C., Morbey M. Hepatitis B and C infection in an institution for the developmentally handicapped. N Engl J Med. 1992 Dec 31;327(27):1953–1953. doi: 10.1056/NEJM199212313272713. [DOI] [PubMed] [Google Scholar]
  49. Chayama K., Saitoh S., Arase Y., Ikeda K., Matsumoto T., Sakai Y., Kobayashi M., Unakami M., Morinaga T., Kumada H. Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. Hepatology. 1991 Jun;13(6):1040–1043. [PubMed] [Google Scholar]
  50. Chazouilleres O., Kim M., Combs C., Ferrell L., Bacchetti P., Roberts J., Ascher N. L., Neuwald P., Wilber J., Urdea M. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology. 1994 Apr;106(4):994–999. doi: 10.1016/0016-5085(94)90759-5. [DOI] [PubMed] [Google Scholar]
  51. Chemello L., Cavalletto D., Pontisso P., Bortolotti F., Donada C., Donadon V., Frezza M., Casarin P., Alberti A. Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease. Hepatology. 1993 Feb;17(2):179–182. [PubMed] [Google Scholar]
  52. Chien D. Y., Choo Q. L., Tabrizi A., Kuo C., McFarland J., Berger K., Lee C., Shuster J. R., Nguyen T., Moyer D. L. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: reevaluation of the role of HCV in liver disease. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10011–10015. doi: 10.1073/pnas.89.21.10011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Ching W. M., Wychowski C., Beach M. J., Wang H., Davies C. L., Carl M., Bradley D. W., Alter H. J., Feinstone S. M., Shih J. W. Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3190–3194. doi: 10.1073/pnas.89.8.3190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Choo Q. L., Kuo G., Ralston R., Weiner A., Chien D., Van Nest G., Han J., Berger K., Thudium K., Kuo C. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1294–1298. doi: 10.1073/pnas.91.4.1294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989 Apr 21;244(4902):359–362. doi: 10.1126/science.2523562. [DOI] [PubMed] [Google Scholar]
  56. Choo Q. L., Richman K. H., Han J. H., Berger K., Lee C., Dong C., Gallegos C., Coit D., Medina-Selby R., Barr P. J. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2451–2455. doi: 10.1073/pnas.88.6.2451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Chu C. M., Sheen I. S., Liaw Y. F. The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B. Gastroenterology. 1994 Jul;107(1):189–195. doi: 10.1016/0016-5085(94)90076-0. [DOI] [PubMed] [Google Scholar]
  58. Claeys H., Volckaerts A., De Beenhouwer H., Vermylen C. Association of hepatitis C virus carrier state with the occurrence of hepatitis C virus core antibodies. J Med Virol. 1992 Apr;36(4):259–264. doi: 10.1002/jmv.1890360405. [DOI] [PubMed] [Google Scholar]
  59. Contreras M., Barbara J. A., Anderson C. C., Ranasinghe E., Moore C., Brennan M. T., Howell D. R., Aloysius S., Yardumian A. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology. Lancet. 1991 Mar 30;337(8744):753–757. doi: 10.1016/0140-6736(91)91370-a. [DOI] [PubMed] [Google Scholar]
  60. Cunningham S. J., Cunningham R., Izmeth M. G., Baker B., Hart C. A. Seroprevalence of hepatitis B and C in a Merseyside hospital for the mentally handicapped. Epidemiol Infect. 1994 Feb;112(1):195–200. doi: 10.1017/s0950268800057563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Cuypers H. T., Bresters D., Winkel I. N., Reesink H. W., Weiner A. J., Houghton M., van der Poel C. L., Lelie P. N. Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus. J Clin Microbiol. 1992 Dec;30(12):3220–3224. doi: 10.1128/jcm.30.12.3220-3224.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Czaja A. J., Carpenter H. A. Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology. 1993 Dec;105(6):1824–1832. doi: 10.1016/0016-5085(93)91081-r. [DOI] [PubMed] [Google Scholar]
  63. Davis G. L., Balart L. A., Schiff E. R., Lindsay K., Bodenheimer H. C., Jr, Perrillo R. P., Carey W., Jacobson I. M., Payne J., Dienstag J. L. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. N Engl J Med. 1989 Nov 30;321(22):1501–1506. doi: 10.1056/NEJM198911303212203. [DOI] [PubMed] [Google Scholar]
  64. Davis G. L., Lau J. Y., Urdea M. S., Neuwald P. D., Wilber J. C., Lindsay K., Perrillo R. P., Albrecht J. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology. 1994 Jun;19(6):1337–1341. [PubMed] [Google Scholar]
  65. De Beenhouwer H., Verhaert H., Claeys H., Vermylen C. Confirmation of hepatitis C virus positive blood donors by immunoblotting and polymerase chain reaction. Vox Sang. 1992;63(3):198–203. doi: 10.1111/j.1423-0410.1992.tb05100.x. [DOI] [PubMed] [Google Scholar]
  66. DeCastro M., Sánchez J., Herrera J. F., Cháves A., Durán R., García-Buey L., García-Monzón C., Sequí J., Moreno-Otero R. Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology. 1993 Apr;17(4):551–557. doi: 10.1002/hep.1840170405. [DOI] [PubMed] [Google Scholar]
  67. Di Bisceglie A. M., Goodman Z. D., Ishak K. G., Hoofnagle J. H., Melpolder J. J., Alter H. J. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology. 1991 Dec;14(6):969–974. doi: 10.1016/0270-9139(91)90113-a. [DOI] [PubMed] [Google Scholar]
  68. Di Bisceglie A. M., Hoofnagle J. H., Krawczynski K. Changes in hepatitis C virus antigen in liver with antiviral therapy. Gastroenterology. 1993 Sep;105(3):858–862. doi: 10.1016/0016-5085(93)90905-r. [DOI] [PubMed] [Google Scholar]
  69. Di Bisceglie A. M., Martin P., Kassianides C., Lisker-Melman M., Murray L., Waggoner J., Goodman Z., Banks S. M., Hoofnagle J. H. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med. 1989 Nov 30;321(22):1506–1510. doi: 10.1056/NEJM198911303212204. [DOI] [PubMed] [Google Scholar]
  70. Di Bisceglie A. M., Shindo M., Fong T. L., Fried M. W., Swain M. G., Bergasa N. V., Axiotis C. A., Waggoner J. G., Park Y., Hoofnagle J. H. A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology. 1992 Sep;16(3):649–654. doi: 10.1002/hep.1840160307. [DOI] [PubMed] [Google Scholar]
  71. Dindzans V. J. Viral hepatitis. Preexposure and postexposure prophylaxis. Postgrad Med. 1992 Sep 15;92(4):43-6, 49-52. doi: 10.1080/00325481.1992.11701464. [DOI] [PubMed] [Google Scholar]
  72. Dittmann S., Roggendorf M., Dürkop J., Wiese M., Lorbeer B., Deinhardt F. Long-term persistence of hepatitis C virus antibodies in a single source outbreak. J Hepatol. 1991 Nov;13(3):323–327. doi: 10.1016/0168-8278(91)90076-n. [DOI] [PubMed] [Google Scholar]
  73. Donahue J. G., Muñoz A., Ness P. M., Brown D. E., Jr, Yawn D. H., McAllister H. A., Jr, Reitz B. A., Nelson K. E. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med. 1992 Aug 6;327(6):369–373. doi: 10.1056/NEJM199208063270601. [DOI] [PubMed] [Google Scholar]
  74. Dow B. C., Coote I., Munro H., McOmish F., Yap P. L., Simmonds P., Follett E. A. Confirmation of hepatitis C virus antibody in blood donors. J Med Virol. 1993 Nov;41(3):215–220. doi: 10.1002/jmv.1890410309. [DOI] [PubMed] [Google Scholar]
  75. Dugan M. J., Rouch D. A., Akard L. P., Sperl B. G., Black J. R., Markham R. E., Jr, Jansen J. Successful allogeneic bone marrow transplantation in an adult with aplastic anemia following orthotopic liver transplantation for non-A, non-B, non-C hepatitis. Bone Marrow Transplant. 1993 Oct;12(4):417–419. [PubMed] [Google Scholar]
  76. Eckart M. R., Selby M., Masiarz F., Lee C., Berger K., Crawford K., Kuo C., Kuo G., Houghton M., Choo Q. L. The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor. Biochem Biophys Res Commun. 1993 Apr 30;192(2):399–406. doi: 10.1006/bbrc.1993.1429. [DOI] [PubMed] [Google Scholar]
  77. Erickson A. L., Houghton M., Choo Q. L., Weiner A. J., Ralston R., Muchmore E., Walker C. M. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J Immunol. 1993 Oct 15;151(8):4189–4199. [PubMed] [Google Scholar]
  78. Everhart J. E., Di Bisceglie A. M., Murray L. M., Alter H. J., Melpolder J. J., Kuo G., Hoofnagle J. H. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med. 1990 Apr 1;112(7):544–545. doi: 10.7326/0003-4819-112-7-544. [DOI] [PubMed] [Google Scholar]
  79. Eyster M. E., Alter H. J., Aledort L. M., Quan S., Hatzakis A., Goedert J. J. Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med. 1991 Nov 15;115(10):764–768. doi: 10.7326/0003-4819-115-10-764. [DOI] [PubMed] [Google Scholar]
  80. Failla C., Tomei L., De Francesco R. Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins. J Virol. 1994 Jun;68(6):3753–3760. doi: 10.1128/jvi.68.6.3753-3760.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Fan F. S., Tzeng C. H., Hsiao K. I., Hu S. T., Liu W. T., Chen P. M. Withdrawal of immunosuppressive therapy in allogeneic bone marrow transplantation reactivates chronic viral hepatitis C. Bone Marrow Transplant. 1991 Nov;8(5):417–420. [PubMed] [Google Scholar]
  82. Farci P., Alter H. J., Govindarajan S., Wong D. C., Engle R., Lesniewski R. R., Mushahwar I. K., Desai S. M., Miller R. H., Ogata N. Lack of protective immunity against reinfection with hepatitis C virus. Science. 1992 Oct 2;258(5079):135–140. doi: 10.1126/science.1279801. [DOI] [PubMed] [Google Scholar]
  83. Farci P., London W. T., Wong D. C., Dawson G. J., Vallari D. S., Engle R., Purcell R. H. The natural history of infection with hepatitis C virus (HCV) in chimpanzees: comparison of serologic responses measured with first- and second-generation assays and relationship to HCV viremia. J Infect Dis. 1992 Jun;165(6):1006–1011. doi: 10.1093/infdis/165.6.1006. [DOI] [PubMed] [Google Scholar]
  84. Fargion S., Piperno A., Cappellini M. D., Sampietro M., Fracanzani A. L., Romano R., Caldarelli R., Marcelli R., Vecchi L., Fiorelli G. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology. 1992 Dec;16(6):1322–1326. doi: 10.1002/hep.1840160603. [DOI] [PubMed] [Google Scholar]
  85. Feinstone S. M., Kapikian A. Z., Purcell R. H., Alter H. J., Holland P. V. Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med. 1975 Apr 10;292(15):767–770. doi: 10.1056/NEJM197504102921502. [DOI] [PubMed] [Google Scholar]
  86. Ferrari C., Valli A., Galati L., Penna A., Scaccaglia P., Giuberti T., Schianchi C., Missale G., Marin M. G., Fiaccadori F. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology. 1994 Feb;19(2):286–295. [PubMed] [Google Scholar]
  87. Ferri C., Greco F., Longombardo G., Palla P., Moretti A., Marzo E., Mazzoni A., Pasero G., Bombardieri S., Highfield P. Association between hepatitis C virus and mixed cryoglobulinemia [see comment]. Clin Exp Rheumatol. 1991 Nov-Dec;9(6):621–624. [PubMed] [Google Scholar]
  88. Ferri C., Marzo E., Longombardo G., Lombardini F., La Civita L., Vanacore R., Liberati A. M., Gerli R., Greco F., Moretti A. Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood. 1993 Mar 1;81(5):1132–1136. [PubMed] [Google Scholar]
  89. Fong T. L., Di Bisceglie A. M., Waggoner J. G., Banks S. M., Hoofnagle J. H. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology. 1991 Jul;14(1):64–67. doi: 10.1002/hep.1840140111. [DOI] [PubMed] [Google Scholar]
  90. Fong T. L., Kanel G. C., Conrad A., Valinluck B., Charboneau F., Adkins R. H. Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology. 1994 Mar;19(3):554–557. doi: 10.1002/hep.1840190303. [DOI] [PubMed] [Google Scholar]
  91. Fong T. L., Shindo M., Feinstone S. M., Hoofnagle J. H., Di Bisceglie A. M. Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. J Clin Invest. 1991 Sep;88(3):1058–1060. doi: 10.1172/JCI115368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Fong T. L., Valinluck B., Govindarajan S., Charboneau F., Adkins R. H., Redeker A. G. Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology. 1994 Jul;107(1):196–199. doi: 10.1016/0016-5085(94)90077-9. [DOI] [PubMed] [Google Scholar]
  93. Fong T. L., Valinluck B., Govindarajan S., Rolon N., Lee S. R., Page E., Darner J., Redeker A. G. Marked improvement in sensitivity of second-generation tests for acute hepatitis C virus infection. J Infect Dis. 1993 Aug;168(2):519–520. doi: 10.1093/infdis/168.2.519. [DOI] [PubMed] [Google Scholar]
  94. Fried M. W., Draguesku J. O., Shindo M., Simpson L. H., Banks S. M., Hoofnagle J. H., Di Bisceglie A. M. Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis. Dig Dis Sci. 1993 Apr;38(4):631–636. doi: 10.1007/BF01316792. [DOI] [PubMed] [Google Scholar]
  95. Fried M. W., Shindo M., Fong T. L., Fox P. C., Hoofnagle J. H., Di Bisceglie A. M. Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C. Gastroenterology. 1992 Apr;102(4 Pt 1):1306–1308. [PubMed] [Google Scholar]
  96. Fritsche C., Brandes J. C., Delaney S. R., Gallagher-Lepak S., Menitove J. E., Rich L., Scannell C., Swanson P., Lee H. H. Hepatitis C is a poor prognostic indicator in black kidney transplant recipients. Transplantation. 1993 Jun;55(6):1283–1287. doi: 10.1097/00007890-199306000-00014. [DOI] [PubMed] [Google Scholar]
  97. Féray C., Gigou M., Samuel D., Reyes G., Bernuau J., Reynes M., Bismuth H., Bréchot C. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology. 1993 Feb;104(2):549–555. doi: 10.1016/0016-5085(93)90425-c. [DOI] [PubMed] [Google Scholar]
  98. Féray C., Samuel D., Thiers V., Gigou M., Pichon F., Bismuth A., Reynes M., Maisonneuve P., Bismuth H., Bréchot C. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest. 1992 Apr;89(4):1361–1365. doi: 10.1172/JCI115723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Garson J. A., Clewley J. P., Simmonds P., Zhang L. Q., Mori J., Ring C., Follett E. A., Dow B. C., Martin S., Gunson H. Hepatitis C viraemia in United Kingdom blood donors. A multicentre study. Vox Sang. 1992;62(4):218–223. doi: 10.1111/j.1423-0410.1992.tb01202.x. [DOI] [PubMed] [Google Scholar]
  100. Garson J. A., Lenzi M., Ring C., Cassani F., Ballardini G., Briggs M., Tedder R. S., Bianchi F. B. Hepatitis C viraemia in adults with type 2 autoimmune hepatitis. J Med Virol. 1991 Aug;34(4):223–226. doi: 10.1002/jmv.1890340405. [DOI] [PubMed] [Google Scholar]
  101. Garson J. A., Tedder R. S., Briggs M., Tuke P., Glazebrook J. A., Trute A., Parker D., Barbara J. A., Contreras M., Aloysius S. Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Lancet. 1990 Jun 16;335(8703):1419–1422. doi: 10.1016/0140-6736(90)91446-h. [DOI] [PubMed] [Google Scholar]
  102. Geiger C. P., Caselmann W. H. Non-radioactive hybridization with hepatitis C virus-specific probes created during polymerase chain reaction: a fast and simple procedure to verify hepatitis C virus infection. J Hepatol. 1992 Jul;15(3):387–390. doi: 10.1016/0168-8278(92)90074-y. [DOI] [PubMed] [Google Scholar]
  103. Gerberding J. L., Henderson D. K. Management of occupational exposures to bloodborne pathogens: hepatitis B virus, hepatitis C virus, and human immunodeficiency virus. Clin Infect Dis. 1992 Jun;14(6):1179–1185. doi: 10.1093/clinids/14.6.1179. [DOI] [PubMed] [Google Scholar]
  104. Gil B., Qian C., Riezu-Boj J. I., Civeira M. P., Prieto J. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment. Hepatology. 1993 Nov;18(5):1050–1054. [PubMed] [Google Scholar]
  105. Giuberti T., Ferrari C., Marchelli S., Degli Antoni A. M., Schianchi C., Pizzaferri P., Fiaccadori F. Long-term follow-up of anti-hepatitis C virus antibodies in patients with acute nonA nonB hepatitis and different outcome of liver disease. Liver. 1992 Apr;12(2):94–99. doi: 10.1111/j.1600-0676.1992.tb00564.x. [DOI] [PubMed] [Google Scholar]
  106. Giuberti T., Marin M. G., Ferrari C., Marchelli S., Schianchi C., Degli Antoni A. M., Pizzocolo G., Fiaccadori F. Hepatitis C virus viremia following clinical resolution of acute hepatitis C. J Hepatol. 1994 May;20(5):666–671. doi: 10.1016/s0168-8278(05)80358-7. [DOI] [PubMed] [Google Scholar]
  107. Gladziwa U., Schlipköter U., Lorbeer B., Cholmakow K., Roggendorf M., Sieberth H. G. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study. Clin Nephrol. 1993 Jul;40(1):46–52. [PubMed] [Google Scholar]
  108. Goffin E., Pirson Y., Cornu C., Geubel A., Squifflet J. P., van Ypersele de Strihou C. Outcome of HCV infection after renal transplantation. Kidney Int. 1994 Feb;45(2):551–555. doi: 10.1038/ki.1994.71. [DOI] [PubMed] [Google Scholar]
  109. Grakoui A., McCourt D. W., Wychowski C., Feinstone S. M., Rice C. M. A second hepatitis C virus-encoded proteinase. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10583–10587. doi: 10.1073/pnas.90.22.10583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Grakoui A., McCourt D. W., Wychowski C., Feinstone S. M., Rice C. M. Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol. 1993 May;67(5):2832–2843. doi: 10.1128/jvi.67.5.2832-2843.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Gruber A., Grillner L., Norder H., Magnius L., Björkholm M. Severe aplastic anemia associated with seronegative community-acquired hepatitis C virus infection. Ann Hematol. 1993 Mar;66(3):157–159. doi: 10.1007/BF01697628. [DOI] [PubMed] [Google Scholar]
  112. Gruber A., Lundberg L. G., Björkholm M. Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy. J Intern Med. 1993 Aug;234(2):223–225. doi: 10.1111/j.1365-2796.1993.tb00734.x. [DOI] [PubMed] [Google Scholar]
  113. Hagiwara H., Hayashi N., Mita E., Hiramatsu N., Ueda K., Takehara T., Yuki N., Kasahara A., Fusamoto H., Kamada T. Detection of hepatitis C virus RNA in chronic non-A, non-B liver disease. Gastroenterology. 1992 Feb;102(2):692–694. doi: 10.1016/0016-5085(92)90122-f. [DOI] [PubMed] [Google Scholar]
  114. Hagiwara H., Hayashi N., Mita E., Naito M., Kasahara A., Fusamoto H., Kamada T. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology. 1993 Apr;17(4):545–550. doi: 10.1002/hep.1840170404. [DOI] [PubMed] [Google Scholar]
  115. Hagiwara H., Hayashi N., Mita E., Takehara T., Kasahara A., Fusamoto H., Kamada T. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology. 1993 Mar;104(3):877–883. doi: 10.1016/0016-5085(93)91025-d. [DOI] [PubMed] [Google Scholar]
  116. Hagiwara H., Hayashi N., Mita E., Ueda K., Takehara T., Kasahara A., Fusamoto H., Kamada T. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alpha. Hepatology. 1992 Jan;15(1):37–41. doi: 10.1002/hep.1840150108. [DOI] [PubMed] [Google Scholar]
  117. Hallam N. F., Fletcher M. L., Read S. J., Majid A. M., Kurtz J. B., Rizza C. R. Low risk of sexual transmission of hepatitis C virus. J Med Virol. 1993 Jul;40(3):251–253. doi: 10.1002/jmv.1890400315. [DOI] [PubMed] [Google Scholar]
  118. Han J. H., Shyamala V., Richman K. H., Brauer M. J., Irvine B., Urdea M. S., Tekamp-Olson P., Kuo G., Choo Q. L., Houghton M. Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1711–1715. doi: 10.1073/pnas.88.5.1711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Hanley J. P., Dolan G., Day S., Skidmore S. J., Irving W. L. Interaction of hepatitis B and hepatitis C infection in haemophilia. Br J Haematol. 1993 Nov;85(3):611–612. doi: 10.1111/j.1365-2141.1993.tb03356.x. [DOI] [PubMed] [Google Scholar]
  120. Hardy N. M., Sandroni S., Danielson S., Wilson W. J. Antibody to hepatitis C virus increases with time on hemodialysis. Clin Nephrol. 1992 Jul;38(1):44–48. [PubMed] [Google Scholar]
  121. Hernandez M. E., Bruguera M., Puyuelo T., Barrera J. M., Sanchez Tapias J. M., Rodés J. Risk of needle-stick injuries in the transmission of hepatitis C virus in hospital personnel. J Hepatol. 1992 Sep;16(1-2):56–58. doi: 10.1016/s0168-8278(05)80094-7. [DOI] [PubMed] [Google Scholar]
  122. Herrero C., Vicente A., Bruguera M., Ercilla M. G., Barrera J. M., Vidal J., Terés J., Mascaró J. M., Rodés J. Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet. 1993 Mar 27;341(8848):788–789. doi: 10.1016/0140-6736(93)90562-u. [DOI] [PubMed] [Google Scholar]
  123. Hibbs J. R., Frickhofen N., Rosenfeld S. J., Feinstone S. M., Kojima S., Bacigalupo A., Locasciulli A., Tzakis A. G., Alter H. J., Young N. S. Aplastic anemia and viral hepatitis. Non-A, Non-B, Non-C? JAMA. 1992 Apr 15;267(15):2051–2054. [PubMed] [Google Scholar]
  124. Hijikata M., Mizushima H., Akagi T., Mori S., Kakiuchi N., Kato N., Tanaka T., Kimura K., Shimotohno K. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol. 1993 Aug;67(8):4665–4675. doi: 10.1128/jvi.67.8.4665-4675.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Hino K., Sainokami S., Shimoda K., Iino S., Wang Y., Okamoto H., Miyakawa Y., Mayumi M. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol. 1994 Mar;42(3):299–305. doi: 10.1002/jmv.1890420318. [DOI] [PubMed] [Google Scholar]
  126. Hino K., Sainokami S., Shimoda K., Niwa H., Iino S. Clinical course of acute hepatitis C and changes in HCV markers. Dig Dis Sci. 1994 Jan;39(1):19–27. doi: 10.1007/BF02090055. [DOI] [PubMed] [Google Scholar]
  127. Hiramatsu N., Hayashi N., Haruna Y., Kasahara A., Fusamoto H., Mori C., Fuke I., Okayama H., Kamada T. Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome. Hepatology. 1992 Aug;16(2):306–311. doi: 10.1002/hep.1840160205. [DOI] [PubMed] [Google Scholar]
  128. Honda M., Kaneko S., Unoura M., Kobayashi K., Murakami S. Risk of hepatitis C virus infections through household contact with chronic carriers: analysis of nucleotide sequences. Hepatology. 1993 Jun;17(6):971–976. [PubMed] [Google Scholar]
  129. Hosein B., Fang X., Wang C. Y. Anti-HCV, anti-GOR, and autoimmunity. Lancet. 1992 Apr 4;339(8797):871–871. [PubMed] [Google Scholar]
  130. Hosoda K., Omata M., Yokosuka O., Kato N., Ohto M. Non-A, non-B chronic hepatitis is chronic hepatitis C: a sensitive assay for detection of hepatitis C virus RNA in the liver. Hepatology. 1992 May;15(5):777–781. doi: 10.1002/hep.1840150506. [DOI] [PubMed] [Google Scholar]
  131. Houghton M., Weiner A., Han J., Kuo G., Choo Q. L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease. Hepatology. 1991 Aug;14(2):381–388. [PubMed] [Google Scholar]
  132. Hsieh T. T., Yao D. S., Sheen I. S., Liaw Y. F., Pao C. C. Hepatitis C virus in peripheral blood mononuclear cells. Am J Clin Pathol. 1992 Oct;98(4):392–396. doi: 10.1093/ajcp/98.4.392. [DOI] [PubMed] [Google Scholar]
  133. Hsu H. H., Wright T. L., Luba D., Martin M., Feinstone S. M., Garcia G., Greenberg H. B. Failure to detect hepatitis C virus genome in human secretions with the polymerase chain reaction. Hepatology. 1991 Nov;14(5):763–767. doi: 10.1002/hep.1840140504. [DOI] [PubMed] [Google Scholar]
  134. Hu K. Q., Yu C. H., Vierling J. M. Direct detection of circulating hepatitis C virus RNA using probes from the 5' untranslated region. J Clin Invest. 1992 Jun;89(6):2040–2045. doi: 10.1172/JCI115815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Hyams K. C., Phillips I. A., Moran A. Y., Tejada A., Wignall F. S., Escamilla J. Seroprevalence of hepatitis C antibody in Peru. J Med Virol. 1992 Jun;37(2):127–131. doi: 10.1002/jmv.1890370210. [DOI] [PubMed] [Google Scholar]
  136. Iino S., Hino K., Kuroki T., Suzuki H., Yamamoto S. Treatment of chronic hepatitis C with high-dose interferon alpha-2b. A multicenter study. Dig Dis Sci. 1993 Apr;38(4):612–618. doi: 10.1007/BF01316789. [DOI] [PubMed] [Google Scholar]
  137. Inoue Y., Takeuchi K., Chou W. H., Unayama T., Takahashi K., Saito I., Miyamura T. Silent mother-to-child transmission of hepatitis C virus through two generations determined by comparative nucleotide sequence analysis of the viral cDNA. J Infect Dis. 1992 Dec;166(6):1425–1428. doi: 10.1093/infdis/166.6.1425. [DOI] [PubMed] [Google Scholar]
  138. Irie Y., Hayashi H., Yokozeki K., Kashima T., Okuda K. Hepatitis C infection unrelated to blood transfusion in hemodialysis patients. J Hepatol. 1994 Apr;20(4):557–559. doi: 10.1016/s0168-8278(05)80506-9. [DOI] [PubMed] [Google Scholar]
  139. Jadoul M., Cornu C., van Ypersele de Strihou C. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group. Kidney Int. 1993 Dec;44(6):1322–1326. doi: 10.1038/ki.1993.385. [DOI] [PubMed] [Google Scholar]
  140. Jeffers L. J., Hasan F., De Medina M., Reddy R., Parker T., Silva M., Mendez L., Schiff E. R., Manns M., Houghton M. Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis. Hepatology. 1992 Feb;15(2):187–190. doi: 10.1002/hep.1840150204. [DOI] [PubMed] [Google Scholar]
  141. Johnson R. J., Gretch D. R., Yamabe H., Hart J., Bacchi C. E., Hartwell P., Couser W. G., Corey L., Wener M. H., Alpers C. E. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 1993 Feb 18;328(7):465–470. doi: 10.1056/NEJM199302183280703. [DOI] [PubMed] [Google Scholar]
  142. Jouët P., Roudot-Thoraval F., Dhumeaux D., Métreau J. M. Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C. Gastroenterology. 1994 Mar;106(3):686–690. doi: 10.1016/0016-5085(94)90703-x. [DOI] [PubMed] [Google Scholar]
  143. Kakumu S., Yoshika K., Tanaka K., Higashi Y., Kurokawa S., Hirofuji H., Kusakabe A. Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C. J Med Virol. 1993 Sep;41(1):65–70. doi: 10.1002/jmv.1890410114. [DOI] [PubMed] [Google Scholar]
  144. Kakumu S., Yoshioka K., Wakita T., Ishikawa T., Takayanagi M., Higashi Y. A pilot study of ribavirin and interferon beta for the treatment of chronic hepatitis C. Gastroenterology. 1993 Aug;105(2):507–512. doi: 10.1016/0016-5085(93)90727-t. [DOI] [PubMed] [Google Scholar]
  145. Kaldor J. M., Archer G. T., Buring M. L., Ismay S. L., Kenrick K. G., Lien A. S., Purusothaman K., Tulloch R., Bolton W. V., Wylie B. R. Risk factors for hepatitis C virus infection in blood donors: a case-control study. Med J Aust. 1992 Aug 17;157(4):227–230. doi: 10.5694/j.1326-5377.1992.tb137123.x. [DOI] [PubMed] [Google Scholar]
  146. Kanto T., Hayashi N., Takehara T., Hagiwara H., Mita E., Naito M., Kasahara A., Fusamoto H., Kamada T. Buoyant density of hepatitis C virus recovered from infected hosts: two different features in sucrose equilibrium density-gradient centrifugation related to degree of liver inflammation. Hepatology. 1994 Feb;19(2):296–302. [PubMed] [Google Scholar]
  147. Kao J. H., Chen P. J., Lai M. Y., Chen D. S. Superinfection of heterologous hepatitis C virus in a patient with chronic type C hepatitis. Gastroenterology. 1993 Aug;105(2):583–587. doi: 10.1016/0016-5085(93)90737-w. [DOI] [PubMed] [Google Scholar]
  148. Kao J. H., Chen P. J., Yang P. M., Lai M. Y., Sheu J. C., Wang T. H., Chen D. S. Intrafamilial transmission of hepatitis C virus: the important role of infections between spouses. J Infect Dis. 1992 Oct;166(4):900–903. doi: 10.1093/infdis/166.4.900. [DOI] [PubMed] [Google Scholar]
  149. Katkov W. N., Friedman L. S., Cody H., Evans A., Kuo G., Choo Q. L., Houghton M., Dienstag J. L. Elevated serum alanine aminotransferase levels in blood donors: the contribution of hepatitis C virus. Ann Intern Med. 1991 Dec 1;115(11):882–884. doi: 10.7326/0003-4819-115-11-882. [DOI] [PubMed] [Google Scholar]
  150. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9524–9528. doi: 10.1073/pnas.87.24.9524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  151. Kato N., Sekiya H., Ootsuyama Y., Nakazawa T., Hijikata M., Ohkoshi S., Shimotohno K. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol. 1993 Jul;67(7):3923–3930. doi: 10.1128/jvi.67.7.3923-3930.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Kato N., Yokosuka O., Hosoda K., Ito Y., Ohto M., Omata M. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology. 1993 Jul;18(1):16–20. [PubMed] [Google Scholar]
  153. Kelen G. D., Green G. B., Purcell R. H., Chan D. W., Qaqish B. F., Sivertson K. T., Quinn T. C. Hepatitis B and hepatitis C in emergency department patients. N Engl J Med. 1992 May 21;326(21):1399–1404. doi: 10.1056/NEJM199205213262105. [DOI] [PubMed] [Google Scholar]
  154. Kita H., Moriyama T., Kaneko T., Harase I., Nomura M., Miura H., Nakamura I., Yazaki Y., Imawari M. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology. 1993 Nov;18(5):1039–1044. [PubMed] [Google Scholar]
  155. Kiyosawa K., Sodeyama T., Tanaka E., Gibo Y., Yoshizawa K., Nakano Y., Furuta S., Akahane Y., Nishioka K., Purcell R. H. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 1990 Oct;12(4 Pt 1):671–675. doi: 10.1002/hep.1840120409. [DOI] [PubMed] [Google Scholar]
  156. Kiyosawa K., Sodeyama T., Tanaka E., Nakano Y., Furuta S., Nishioka K., Purcell R. H., Alter H. J. Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med. 1991 Sep 1;115(5):367–369. doi: 10.7326/0003-4819-115-5-367. [DOI] [PubMed] [Google Scholar]
  157. Kiyosawa K., Tanaka E., Sodeyama T., Yoshizawa K., Yabu K., Furuta K., Imai H., Nakano Y., Usuda S., Uemura K. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. The South Kiso Hepatitis Study Group. Gastroenterology. 1994 Jun;106(6):1596–1602. doi: 10.1016/0016-5085(94)90416-2. [DOI] [PubMed] [Google Scholar]
  158. Klein R. S., Freeman K., Taylor P. E., Stevens C. E. Occupational risk for hepatitis C virus infection among New York City dentists. Lancet. 1991 Dec 21;338(8782-8783):1539–1542. doi: 10.1016/0140-6736(91)92369-d. [DOI] [PubMed] [Google Scholar]
  159. Kleinman S., Alter H., Busch M., Holland P., Tegtmeier G., Nelles M., Lee S., Page E., Wilber J., Polito A. Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay. Transfusion. 1992 Nov-Dec;32(9):805–813. doi: 10.1046/j.1537-2995.1992.32993110750.x. [DOI] [PubMed] [Google Scholar]
  160. Ko Y. C., Ho M. S., Chiang T. A., Chang S. J., Chang P. Y. Tattooing as a risk of hepatitis C virus infection. J Med Virol. 1992 Dec;38(4):288–291. doi: 10.1002/jmv.1890380411. [DOI] [PubMed] [Google Scholar]
  161. Kobayashi Y., Watanabe S., Konishi M., Yokoi M., Ikoma J., Kakehashi R., Kojima Y., Suzuki S. Detection of hepatitis C virus RNA by nested polymerase chain reaction in sera of patients with chronic non-A, non-B hepatitis treated with interferon. J Hepatol. 1992 Sep;16(1-2):138–144. doi: 10.1016/s0168-8278(05)80106-0. [DOI] [PubMed] [Google Scholar]
  162. Kobayashi Y., Watanabe S., Konishi M., Yokoi M., Kakehashi R., Kaito M., Kondo M., Hayashi Y., Jomori T., Suzuki S. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-beta. Hepatology. 1993 Dec;18(6):1319–1325. [PubMed] [Google Scholar]
  163. Koretz R. L., Abbey H., Coleman E., Gitnick G. Non-A, non-B post-transfusion hepatitis. Looking back in the second decade. Ann Intern Med. 1993 Jul 15;119(2):110–115. doi: 10.7326/0003-4819-119-2-199307150-00003. [DOI] [PubMed] [Google Scholar]
  164. Koziel M. J., Dudley D., Afdhal N., Choo Q. L., Houghton M., Ralston R., Walker B. D. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol. 1993 Dec;67(12):7522–7532. doi: 10.1128/jvi.67.12.7522-7532.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Koziel M. J., Dudley D., Wong J. T., Dienstag J., Houghton M., Ralston R., Walker B. D. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol. 1992 Nov 15;149(10):3339–3344. [PubMed] [Google Scholar]
  166. Krawczynski K., Beach M. J., Bradley D. W., Kuo G., di Bisceglie A. M., Houghton M., Reyes G. R., Kim J. P., Choo Q. L., Alter M. J. Hepatitis C virus antigen in hepatocytes: immunomorphologic detection and identification. Gastroenterology. 1992 Aug;103(2):622–629. doi: 10.1016/0016-5085(92)90856-t. [DOI] [PubMed] [Google Scholar]
  167. Krogsgaard K., Wantzin P., Mathiesen L. R., Sonne J., Ring-Larsen H. Early appearance of antibodies to hepatitis C virus in community acquired acute non-A, non-B hepatitis is associated with progression to chronic liver disease. The Copenhagen Hepatitis Acuta Programme. Scand J Infect Dis. 1990;22(4):399–402. doi: 10.3109/00365549009027069. [DOI] [PubMed] [Google Scholar]
  168. Kumar U., Brown J., Monjardino J., Thomas H. C. Sequence variation in the large envelope glycoprotein (E2/NS1) of hepatitis C virus during chronic infection. J Infect Dis. 1993 Mar;167(3):726–730. doi: 10.1093/infdis/167.3.726. [DOI] [PubMed] [Google Scholar]
  169. Kumar U., Monjardino J., Thomas H. C. Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology. 1994 Apr;106(4):1072–1075. doi: 10.1016/0016-5085(94)90770-6. [DOI] [PubMed] [Google Scholar]
  170. Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
  171. Kurosaki M., Enomoto N., Marumo F., Sato C. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection. Hepatology. 1993 Dec;18(6):1293–1299. [PubMed] [Google Scholar]
  172. König V., Bauditz J., Lobeck H., Lüsebrink R., Neuhaus P., Blumhardt G., Bechstein W. O., Neuhaus R., Steffen R., Hopf U. Hepatitis C virus reinfection in allografts after orthotopic liver transplantation. Hepatology. 1992 Nov;16(5):1137–1143. doi: 10.1002/hep.1840160506. [DOI] [PubMed] [Google Scholar]
  173. Lacour J. P., Bodokh I., Castanet J., Bekri S., Ortonne J. P. Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol. 1993 Feb;128(2):121–123. doi: 10.1111/j.1365-2133.1993.tb15139.x. [DOI] [PubMed] [Google Scholar]
  174. Lai M. E., Mazzoleni A. P., Argiolu F., De Virgilis S., Balestrieri A., Purcell R. H., Cao A., Farci P. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet. 1994 Feb 12;343(8894):388–390. doi: 10.1016/s0140-6736(94)91224-6. [DOI] [PubMed] [Google Scholar]
  175. Lam J. P., McOmish F., Burns S. M., Yap P. L., Mok J. Y., Simmonds P. Infrequent vertical transmission of hepatitis C virus. J Infect Dis. 1993 Mar;167(3):572–576. doi: 10.1093/infdis/167.3.572. [DOI] [PubMed] [Google Scholar]
  176. Lampertico P., Rumi M., Romeo R., Craxì A., Soffredini R., Biassoni D., Colombo M. A multicenter randomized controlled trial of recombinant interferon-alpha 2b in patients with acute transfusion-associated hepatitis C. Hepatology. 1994 Jan;19(1):19–22. [PubMed] [Google Scholar]
  177. Lanford R. E., Notvall L., Chavez D., White R., Frenzel G., Simonsen C., Kim J. Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells. Virology. 1993 Nov;197(1):225–235. doi: 10.1006/viro.1993.1583. [DOI] [PubMed] [Google Scholar]
  178. Lau J. Y., Davis G. L., Brunson M. E., Qian K. P., Lin H. J., Quan S., DiNello R., Polito A. J., Scornik J. C. Hepatitis C virus infection in kidney transplant recipients. Hepatology. 1993 Nov;18(5):1027–1031. doi: 10.1016/0270-9139(93)90452-s. [DOI] [PubMed] [Google Scholar]
  179. Lau J. Y., Davis G. L., Kniffen J., Qian K. P., Urdea M. S., Chan C. S., Mizokami M., Neuwald P. D., Wilber J. C. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet. 1993 Jun 12;341(8859):1501–1504. doi: 10.1016/0140-6736(93)90635-t. [DOI] [PubMed] [Google Scholar]
  180. Lau J. Y., Davis G. L., Orito E., Qian K. P., Mizokami M. Significance of antibody to the host cellular gene derived epitope GOR in chronic hepatitis C virus infection. J Hepatol. 1993 Feb;17(2):253–257. doi: 10.1016/s0168-8278(05)80047-9. [DOI] [PubMed] [Google Scholar]
  181. Lau J. Y., Mizokami M., Ohno T., Diamond D. A., Kniffen J., Davis G. L. Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C. Lancet. 1993 Nov 13;342(8881):1208–1209. doi: 10.1016/0140-6736(93)92187-x. [DOI] [PubMed] [Google Scholar]
  182. Laycock K. A., Wright T. L., Pepose J. S. Lack of evidence for hepatitis C virus in corneas of seropositive cadavers. Am J Ophthalmol. 1994 Mar 15;117(3):401–402. doi: 10.1016/s0002-9394(14)73153-8. [DOI] [PubMed] [Google Scholar]
  183. Lazizi Y., Elfassi E., Pillot J. Detection of hepatitis C virus sequences in sera with controversial serology by nested polymerase chain reaction. J Clin Microbiol. 1992 Apr;30(4):931–934. doi: 10.1128/jcm.30.4.931-934.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Lee C. H., Cheng C., Wang J., Lumeng L. Identification of hepatitis C viruses with a nonconserved sequence of the 5' untranslated region. J Clin Microbiol. 1992 Jun;30(6):1602–1604. doi: 10.1128/jcm.30.6.1602-1604.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Lee H. S., Han C. J., Kim C. Y. Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area. Cancer. 1993 Nov 1;72(9):2564–2567. doi: 10.1002/1097-0142(19931101)72:9<2564::aid-cncr2820720909>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  186. Lee S. D., Chan C. Y., Wang Y. J., Wu J. C., Lai K. H., Tsai Y. T., Lo K. J. Seroepidemiology of hepatitis C virus infection in Taiwan. Hepatology. 1991 May;13(5):830–833. [PubMed] [Google Scholar]
  187. Lee S., McHutchinson J., Francis B., DiNello R., Polito A., Quan S., Nelles M. Improved detection of antibodies to hepatitis C virus using a second generation ELISA. Adv Exp Med Biol. 1992;312:183–189. doi: 10.1007/978-1-4615-3462-4_19. [DOI] [PubMed] [Google Scholar]
  188. Lefkowitch J. H., Schiff E. R., Davis G. L., Perrillo R. P., Lindsay K., Bodenheimer H. C., Jr, Balart L. A., Ortego T. J., Payne J., Dienstag J. L. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology. 1993 Feb;104(2):595–603. doi: 10.1016/0016-5085(93)90432-c. [DOI] [PubMed] [Google Scholar]
  189. Lehner P. S., Webster A. D. Hepatitis C from immunoglobin infusions. BMJ. 1993 Jun 5;306(6891):1541–1542. doi: 10.1136/bmj.306.6891.1541-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Lenzi M., Ballardini G., Fusconi M., Cassani F., Selleri L., Volta U., Zauli D., Bianchi F. B. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet. 1990 Feb 3;335(8684):258–259. doi: 10.1016/0140-6736(90)90070-l. [DOI] [PubMed] [Google Scholar]
  191. Lenzi M., Johnson P. J., McFarlane I. G., Ballardini G., Smith H. M., McFarlane B. M., Bridger C., Vergani D., Bianchi F. B., Williams R. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet. 1991 Aug 3;338(8762):277–280. doi: 10.1016/0140-6736(91)90418-o. [DOI] [PubMed] [Google Scholar]
  192. Lever A. M., Webster A. D., Brown D., Thomas H. C. Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin. Lancet. 1984 Nov 10;2(8411):1062–1064. doi: 10.1016/s0140-6736(84)91506-x. [DOI] [PubMed] [Google Scholar]
  193. Levey J. M., Bjornsson B., Banner B., Kuhns M., Malhotra R., Whitman N., Romain P. L., Cropley T. G., Bonkovsky H. L. Mixed cryoglobulinemia in chronic hepatitis C infection. A clinicopathologic analysis of 10 cases and review of recent literature. Medicine (Baltimore) 1994 Jan;73(1):53–67. doi: 10.1097/00005792-199401000-00005. [DOI] [PubMed] [Google Scholar]
  194. Levinson W. M., Wormser G. P., Forseter G., Calmann M., O'Brien T. A. Hepatitis C virus seroprevalence in the developmentally disabled. Arch Intern Med. 1992 Nov;152(11):2309–2311. [PubMed] [Google Scholar]
  195. Liang T. J., Jeffers L. J., Reddy K. R., De Medina M., Parker I. T., Cheinquer H., Idrovo V., Rabassa A., Schiff E. R. Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology. 1993 Dec;18(6):1326–1333. [PubMed] [Google Scholar]
  196. Liang T. J., Jeffers L., Reddy R. K., Silva M. O., Cheinquer H., Findor A., De Medina M., Yarbough P. O., Reyes G. R., Schiff E. R. Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses. Gastroenterology. 1993 Feb;104(2):556–562. doi: 10.1016/0016-5085(93)90426-d. [DOI] [PubMed] [Google Scholar]
  197. Liang T. J., Rustgi V., Galun E., Blum H. E. HCV RNA in patients with chronic hepatitis C treated with interferon-alpha. J Med Virol. 1993 May;40(1):69–75. doi: 10.1002/jmv.1890400114. [DOI] [PubMed] [Google Scholar]
  198. Lin H. H., Kao J. H., Hsu H. Y., Ni Y. H., Yeh S. H., Hwang L. H., Chang M. H., Hwang S. C., Chen P. J., Chen D. S. Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus. J Infect Dis. 1994 Mar;169(3):638–641. doi: 10.1093/infdis/169.3.638. [DOI] [PubMed] [Google Scholar]
  199. Lin H. J., Shi N., Mizokami M., Hollinger F. B. Polymerase chain reaction assay for hepatitis C virus RNA using a single tube for reverse transcription and serial rounds of amplification with nested primer pairs. J Med Virol. 1992 Nov;38(3):220–225. doi: 10.1002/jmv.1890380312. [DOI] [PubMed] [Google Scholar]
  200. Lissen E., Alter H. J., Abad M. A., Torres Y., Pérez-Romero M., Leal M., Pineda J. A., Torronteras R., Sánchez-Quijano A. Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases. Eur J Clin Microbiol Infect Dis. 1993 Nov;12(11):827–831. doi: 10.1007/BF02000402. [DOI] [PubMed] [Google Scholar]
  201. Lok A. S., Cheung R., Chan R., Liu V. Hepatitis C viremia in patients with hepatitis C virus infection. Hepatology. 1992 Jun;15(6):1007–1012. doi: 10.1002/hep.1840150606. [DOI] [PubMed] [Google Scholar]
  202. Lok A. S., Chien D., Choo Q. L., Chan T. M., Chiu E. K., Cheng I. K., Houghton M., Kuo G. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients. Hepatology. 1993 Sep;18(3):497–502. [PubMed] [Google Scholar]
  203. Lok A. S., Ma O. C., Chan T. M., Lai C. L., Chung H. T., Ng C. P., Lam J. S. Overestimation of the prevalence of antibody to hepatitis C virus in retrospective studies on stored sera. Hepatology. 1991 Nov;14(5):756–762. doi: 10.1002/hep.1840140503. [DOI] [PubMed] [Google Scholar]
  204. Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology. 1993 Jul;105(1):274–278. doi: 10.1016/0016-5085(93)90037-d. [DOI] [PubMed] [Google Scholar]
  205. Lumbreras C., Delgado R., Fuertes A., Loinaz C., Iglesias J., Colina F., Aguado J. M., Gimeno C., Garcia I., Lizasoain M. Clinical significance of hepatitis C virus (HCV) infection in liver transplant recipients. Role of serology and HCV RNA detection. Dig Dis Sci. 1994 May;39(5):965–969. doi: 10.1007/BF02087545. [DOI] [PubMed] [Google Scholar]
  206. Lunel F., Abuaf N., Frangeul L., Grippon P., Perrin M., Le Coz Y., Valla D., Borotto E., Yamamoto A. M., Huraux J. M. Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology. 1992 Sep;16(3):630–636. doi: 10.1002/hep.1840160304. [DOI] [PubMed] [Google Scholar]
  207. Luo K. X., Liang Z. S., Yang S. C., Zhou R., Meng Q. H., Zhu Y. W., He H. T., Jiang S. Etiological investigation of acute post-transfusion non-A, non-B hepatitis in China. J Med Virol. 1993 Mar;39(3):219–223. doi: 10.1002/jmv.1890390308. [DOI] [PubMed] [Google Scholar]
  208. Mac Kenzie W. R., Davis J. P., Peterson D. E., Hibbard A. J., Becker G., Zarvan B. S. Multiple false-positive serologic tests for HIV, HTLV-1, and hepatitis C following influenza vaccination, 1991. JAMA. 1992 Aug 26;268(8):1015–1017. [PubMed] [Google Scholar]
  209. Machida A., Ohnuma H., Tsuda F., Munekata E., Tanaka T., Akahane Y., Okamoto H., Mishiro S. Two distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core protein. Hepatology. 1992 Oct;16(4):886–891. doi: 10.1002/hep.1840160406. [DOI] [PubMed] [Google Scholar]
  210. Magrin S., Craxi A., Fabiano C., Fiorentino G., Almasio P., Palazzo U., Pinzello G., Provenzano G., Pagliaro L., Choo Q. L. Hepatitis C virus replication in 'autoimmune' chronic hepatitis. J Hepatol. 1991 Nov;13(3):364–367. doi: 10.1016/0168-8278(91)90082-m. [DOI] [PubMed] [Google Scholar]
  211. Magrin S., Craxi A., Fabiano C., Simonetti R. G., Fiorentino G., Marino L., Diquattro O., Di Marco V., Loiacono O., Volpes R. Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment. Hepatology. 1994 Feb;19(2):273–279. [PubMed] [Google Scholar]
  212. Magrin S., Craxì A., Fabiano C., Fiorentino G., Marino L., Almasio P., Pinzello G. B., Palazzo U., Vitale M., Maggio A. Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis. J Med Virol. 1992 Nov;38(3):200–206. doi: 10.1002/jmv.1890380309. [DOI] [PubMed] [Google Scholar]
  213. Makris M., Preston F. E., Triger D. R., Underwood J. C., Choo Q. L., Kuo G., Houghton M. Hepatitis C antibody and chronic liver disease in haemophilia. Lancet. 1990 May 12;335(8698):1117–1119. doi: 10.1016/0140-6736(90)91124-s. [DOI] [PubMed] [Google Scholar]
  214. Manabe N., Chevallier M., Chossegros P., Causse X., Guerret S., Trépo C., Grimaud J. A. Interferon-alpha 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: a quantitative histological evaluation. Hepatology. 1993 Dec;18(6):1344–1349. [PubMed] [Google Scholar]
  215. Manabe S., Fuke I., Tanishita O., Kaji C., Gomi Y., Yoshida S., Mori C., Takamizawa A., Yosida I., Okayama H. Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3. Virology. 1994 Feb;198(2):636–644. doi: 10.1006/viro.1994.1075. [DOI] [PubMed] [Google Scholar]
  216. Mangia A., Vallari D. S., Di Bisceglie A. M. Use of confirmatory assays for diagnosis of hepatitis C viral infection in patients with hepatocellular carcinoma. J Med Virol. 1994 Jun;43(2):125–128. doi: 10.1002/jmv.1890430205. [DOI] [PubMed] [Google Scholar]
  217. Manns M. P., Griffin K. J., Sullivan K. F., Johnson E. F. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest. 1991 Oct;88(4):1370–1378. doi: 10.1172/JCI115443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  218. Marcellin P., Martinot-Peignoux M., Gabriel F., Branger M., Degott C., Elias A., Xu L. Z., Larzul D., Erlinger S., Benhamou J. P. Chronic non-B, non-C hepatitis among blood donors assessed with HCV third generation tests and polymerase chain reaction. J Hepatol. 1993 Aug;19(1):167–170. doi: 10.1016/s0168-8278(05)80190-4. [DOI] [PubMed] [Google Scholar]
  219. Marcellin P., Pouteau M., Renard P., Grynblat J. M., Colas Linhart N., Bardet P., Bok B., Benhamou J. P. Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C. Gut. 1992 Jun;33(6):855–856. doi: 10.1136/gut.33.6.855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  220. Mariani G., Di Paolantonio T., Baklaya R., Morfini M., Mannucci P. M. Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: parallel evaluation of other markers for lipid-enveloped and non-lipid-enveloped viruses. The Ad Hoc Study Group of the Fondazione dell'Emofilia. Transfusion. 1993 Oct;33(10):814–818. doi: 10.1046/j.1537-2995.1993.331094054617.x. [DOI] [PubMed] [Google Scholar]
  221. Martell M., Esteban J. I., Quer J., Genescà J., Weiner A., Esteban R., Guardia J., Gómez J. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol. 1992 May;66(5):3225–3229. doi: 10.1128/jvi.66.5.3225-3229.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  222. Martin P., Di Bisceglie A. M., Kassianides C., Lisker-Melman M., Hoofnagle J. H. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology. 1989 Dec;97(6):1559–1561. doi: 10.1016/0016-5085(89)90405-8. [DOI] [PubMed] [Google Scholar]
  223. Mathiesen U. L., Ekermo B., Foberg U., Franzén L., Frydén A., Norlin R., Pettersson L. G., Sterling H., Widell A., Bodemar G. Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas. Scand J Gastroenterol. 1992 Jun;27(6):443–448. doi: 10.3109/00365529209000103. [DOI] [PubMed] [Google Scholar]
  224. Matsumoto A., Tanaka E., Suzuki T., Ogata H., Kiyosawa K. Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C. Dig Dis Sci. 1994 Jun;39(6):1273–1280. doi: 10.1007/BF02093793. [DOI] [PubMed] [Google Scholar]
  225. Mattsson L., Grillner L., Weiland O. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden with a second generation test. Scand J Infect Dis. 1992;24(1):15–20. doi: 10.3109/00365549209048395. [DOI] [PubMed] [Google Scholar]
  226. Mazzella G., Salzetta A., Casanova S., Morelli M. C., Villanova N., Miniero R., Sottili S., Novelli V., Cipolla A., Festi D. Treatment of chronic sporadic-type non-A, non-B hepatitis with lymphoblastoid interferon: gamma GT levels predictive for response. Dig Dis Sci. 1994 Apr;39(4):866–870. doi: 10.1007/BF02087435. [DOI] [PubMed] [Google Scholar]
  227. McCaughan G. W., McGuinness P. H., Bishop G. A., Painter D. M., Lien A. S., Tulloch R., Wylie B. R., Archer G. T. Clinical assessment and incidence of hepatitis C RNA in 50 consecutive RIBA-positive volunteer blood donors. Med J Aust. 1992 Aug 17;157(4):231–233. doi: 10.5694/j.1326-5377.1992.tb137124.x. [DOI] [PubMed] [Google Scholar]
  228. McDonnell W. M. Gene transfer as a new mode of vaccination: implications for HCV. Hepatology. 1993 Sep;18(3):696–698. [PubMed] [Google Scholar]
  229. McFarlane I. G., Smith H. M., Johnson P. J., Bray G. P., Vergani D., Williams R. Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? Lancet. 1990 Mar 31;335(8692):754–757. doi: 10.1016/0140-6736(90)90870-b. [DOI] [PubMed] [Google Scholar]
  230. McGuinness P. H., Bishop G. A., Lien A., Wiley B., Parsons C., McCaughan G. W. Detection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors. Hepatology. 1993 Sep;18(3):485–490. [PubMed] [Google Scholar]
  231. McGuinness P. H., Bishop G. A., McCaughan G. W., Trowbridge R., Gowans E. J. False detection of negative-strand hepatitis C virus RNA. Lancet. 1994 Feb 26;343(8896):551–552. [PubMed] [Google Scholar]
  232. McHutchison J. G., Person J. L., Govindarajan S., Valinluck B., Gore T., Lee S. R., Nelles M., Polito A., Chien D., DiNello R. Improved detection of hepatitis C virus antibodies in high-risk populations. Hepatology. 1992 Jan;15(1):19–25. doi: 10.1002/hep.1840150105. [DOI] [PubMed] [Google Scholar]
  233. McOmish F., Chan S. W., Dow B. C., Gillon J., Frame W. D., Crawford R. J., Yap P. L., Follett E. A., Simmonds P. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion. 1993 Jan;33(1):7–13. doi: 10.1046/j.1537-2995.1993.33193142314.x. [DOI] [PubMed] [Google Scholar]
  234. Melbye M., Biggar R. J., Wantzin P., Krogsgaard K., Ebbesen P., Becker N. G. Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men. BMJ. 1990 Jul 28;301(6745):210–212. doi: 10.1136/bmj.301.6745.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  235. Mendenhall C. L., Seeff L., Diehl A. M., Ghosn S. J., French S. W., Gartside P. S., Rouster S. D., Buskell-Bales Z., Grossman C. J., Roselle G. A. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. The VA Cooperative Study Group (No. 119) Hepatology. 1991 Oct;14(4 Pt 1):581–589. doi: 10.1016/0270-9139(91)90042-t. [DOI] [PubMed] [Google Scholar]
  236. Merican I., Sherlock S., McIntyre N., Dusheiko G. M. Clinical, biochemical and histological features in 102 patients with chronic hepatitis C virus infection. Q J Med. 1993 Feb;86(2):119–125. [PubMed] [Google Scholar]
  237. Michel G., Ritter A., Gerken G., Meyer zum Büschenfelde K. H., Decker R., Manns M. P. Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet. 1992 Feb 1;339(8788):267–269. doi: 10.1016/0140-6736(92)91332-3. [DOI] [PubMed] [Google Scholar]
  238. Michitaka K., Durazzo M., Tillmann H. L., Walker D., Philipp T., Manns M. P. Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2. Gastroenterology. 1994 Jun;106(6):1603–1610. doi: 10.1016/0016-5085(94)90417-0. [DOI] [PubMed] [Google Scholar]
  239. Mimms L. T., Mosley J. W., Hollinger F. B., Aach R. D., Stevens C. E., Cunningham M., Vallari D. V., Barbosa L. H., Nemo G. J. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. BMJ. 1993 Oct 30;307(6912):1095–1097. doi: 10.1136/bmj.307.6912.1095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  240. Mink M. A., Benichou S., Madaule P., Tiollais P., Prince A. M., Inchauspe G. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library. Virology. 1994 Apr;200(1):246–255. doi: 10.1006/viro.1994.1182. [DOI] [PubMed] [Google Scholar]
  241. Misiani R., Bellavita P., Fenili D., Borelli G., Marchesi D., Massazza M., Vendramin G., Comotti B., Tanzi E., Scudeller G. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med. 1992 Oct 1;117(7):573–577. doi: 10.7326/0003-4819-117-7-573. [DOI] [PubMed] [Google Scholar]
  242. Misiani R., Bellavita P., Fenili D., Vicari O., Marchesi D., Sironi P. L., Zilio P., Vernocchi A., Massazza M., Vendramin G. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med. 1994 Mar 17;330(11):751–756. doi: 10.1056/NEJM199403173301104. [DOI] [PubMed] [Google Scholar]
  243. Mita E., Hayashi N., Hagiwara H., Ueda K., Kanazawa Y., Kasahara A., Fusamoto H., Kamada T. Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Dig Dis Sci. 1994 May;39(5):977–982. doi: 10.1007/BF02087547. [DOI] [PubMed] [Google Scholar]
  244. Mitsui T., Iwano K., Masuko K., Yamazaki C., Okamoto H., Tsuda F., Tanaka T., Mishiro S. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology. 1992 Nov;16(5):1109–1114. [PubMed] [Google Scholar]
  245. Miyamoto H., Okamoto H., Sato K., Tanaka T., Mishiro S. Extraordinarily low density of hepatitis C virus estimated by sucrose density gradient centrifugation and the polymerase chain reaction. J Gen Virol. 1992 Mar;73(Pt 3):715–718. doi: 10.1099/0022-1317-73-3-715. [DOI] [PubMed] [Google Scholar]
  246. Murakawa K., Esumi M., Kato T., Kambara H., Shikata T. Heterogeneity within the nonstructural protein 5-encoding region of hepatitis C viruses from a single patient. Gene. 1992 Aug 15;117(2):229–232. doi: 10.1016/0378-1119(92)90733-6. [DOI] [PubMed] [Google Scholar]
  247. Müller H. M., Pfaff E., Goeser T., Kallinowski B., Solbach C., Theilmann L. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J Gen Virol. 1993 Apr;74(Pt 4):669–676. doi: 10.1099/0022-1317-74-4-669. [DOI] [PubMed] [Google Scholar]
  248. Nagayama R., Miyake K., Tsuda F., Okamoto H. IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C. J Med Virol. 1994 Mar;42(3):311–317. doi: 10.1002/jmv.1890420320. [DOI] [PubMed] [Google Scholar]
  249. Nagayama R., Tsuda F., Okamoto H., Wang Y., Mitsui T., Tanaka T., Miyakawa Y., Mayumi M. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein. J Clin Invest. 1993 Sep;92(3):1529–1533. doi: 10.1172/JCI116731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  250. Nakatsuji Y., Matsumoto A., Tanaka E., Ogata H., Kiyosawa K. Detection of chronic hepatitis C virus infection by four diagnostic systems: first-generation and second-generation enzyme-linked immunosorbent assay, second-generation recombinant immunoblot assay and nested polymerase chain reaction analysis. Hepatology. 1992 Aug;16(2):300–305. doi: 10.1002/hep.1840160204. [DOI] [PubMed] [Google Scholar]
  251. Nakazawa T., Kato N., Ootsuyama Y., Sekiya H., Fujioka T., Shibuya A., Shimotohno K. Genetic alteration of the hepatitis C virus hypervariable region obtained from an asymptomatic carrier. Int J Cancer. 1994 Jan 15;56(2):204–207. doi: 10.1002/ijc.2910560210. [DOI] [PubMed] [Google Scholar]
  252. Nalpas B., Thiers V., Pol S., Driss F., Thepot V., Berthelot P., Brechot C. Hepatitis C viremia and anti-HCV antibodies in alcoholics. J Hepatol. 1992 Mar;14(2-3):381–384. doi: 10.1016/0168-8278(92)90187-t. [DOI] [PubMed] [Google Scholar]
  253. Nanda S. K., Yalcinkaya K., Panigrahi A. K., Acharya S. K., Jameel S., Panda S. K. Etiological role of hepatitis E virus in sporadic fulminant hepatitis. J Med Virol. 1994 Feb;42(2):133–137. doi: 10.1002/jmv.1890420207. [DOI] [PubMed] [Google Scholar]
  254. Nasoff M. S., Zebedee S. L., Inchauspé G., Prince A. M. Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5462–5466. doi: 10.1073/pnas.88.12.5462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  255. Negro F., Pacchioni D., Shimizu Y., Miller R. H., Bussolati G., Purcell R. H., Bonino F. Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2247–2251. doi: 10.1073/pnas.89.6.2247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  256. Nishiguchi S., Kuroki T., Ueda T., Fukuda K., Takeda T., Nakajima S., Shiomi S., Kobayashi K., Otani S., Hayashi N. Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis. Ann Intern Med. 1992 Jan 1;116(1):21–25. doi: 10.7326/0003-4819-116-1-21. [DOI] [PubMed] [Google Scholar]
  257. Nishiguchi S., Kuroki T., Yabusako T., Seki S., Kobayashi K., Monna T., Otani S., Sakurai M., Shikata T., Yamamoto S. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease. Hepatology. 1991 Dec;14(6):985–989. [PubMed] [Google Scholar]
  258. Nouri Aria K. T., Sallie R., Sangar D., Alexander G. J., Smith H., Byrne J., Portmann B., Eddleston A. L., Williams R. Detection of genomic and intermediate replicative strands of hepatitis C virus in liver tissue by in situ hybridization. J Clin Invest. 1993 May;91(5):2226–2234. doi: 10.1172/JCI116449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  259. Novati R., Thiers V., Monforte A. D., Maisonneuve P., Principi N., Conti M., Lazzarin A., Brechot C. Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction. J Infect Dis. 1992 Apr;165(4):720–723. doi: 10.1093/infdis/165.4.720. [DOI] [PubMed] [Google Scholar]
  260. Nowak T., Gregersen J. P., Klockmann U., Cummins L. B., Hilfenhaus J. Virus safety of human immunoglobulins: efficient inactivation of hepatitis C and other human pathogenic viruses by the manufacturing procedure. J Med Virol. 1992 Mar;36(3):209–216. doi: 10.1002/jmv.1890360311. [DOI] [PubMed] [Google Scholar]
  261. Numata N., Ohori H., Hayakawa Y., Saitoh Y., Tsunoda A., Kanno A. Demonstration of hepatitis C virus genome in saliva and urine of patients with type C hepatitis: usefulness of the single round polymerase chain reaction method for detection of the HCV genome. J Med Virol. 1993 Oct;41(2):120–128. doi: 10.1002/jmv.1890410207. [DOI] [PubMed] [Google Scholar]
  262. Ogata N., Alter H. J., Miller R. H., Purcell R. H. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3392–3396. doi: 10.1073/pnas.88.8.3392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  263. Oguchi H., Miyasaka M., Tokunaga S., Hora K., Ichikawa S., Ochi T., Yamada K., Nagasawa M., Kanno Y., Aizawa T. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Clin Nephrol. 1992 Jul;38(1):36–43. [PubMed] [Google Scholar]
  264. Ohnishi K., Nomura F., Iida S. Treatment of posttransfusion non-A, non-B acute and chronic hepatitis with human fibroblast beta-interferon: a preliminary report. Am J Gastroenterol. 1989 Jun;84(6):596–600. [PubMed] [Google Scholar]
  265. Ohto H., Terazawa S., Sasaki N., Sasaki N., Hino K., Ishiwata C., Kako M., Ujiie N., Endo C., Matsui A. Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group. N Engl J Med. 1994 Mar 17;330(11):744–750. doi: 10.1056/NEJM199403173301103. [DOI] [PubMed] [Google Scholar]
  266. Okada S., Akahane Y., Suzuki H., Okamoto H., Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology. 1992 Sep;16(3):619–624. doi: 10.1002/hep.1840160302. [DOI] [PubMed] [Google Scholar]
  267. Okamoto H., Kojima M., Okada S., Yoshizawa H., Iizuka H., Tanaka T., Muchmore E. E., Peterson D. A., Ito Y., Mishiro S. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology. 1992 Oct;190(2):894–899. doi: 10.1016/0042-6822(92)90933-g. [DOI] [PubMed] [Google Scholar]
  268. Omata M., Yokosuka O., Takano S., Kato N., Hosoda K., Imazeki F., Tada M., Ito Y., Ohto M. Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet. 1991 Oct 12;338(8772):914–915. doi: 10.1016/0140-6736(91)91774-o. [DOI] [PubMed] [Google Scholar]
  269. Oshita M., Hayashi N., Kasahara A., Yuki N., Takehara T., Hagiwara H., Hayakawa Y., Yasumatsuya Y., Kishida Y., Fusamoto H. Prevalence of hepatitis C virus in family members of patients with hepatitis C. J Med Virol. 1993 Nov;41(3):251–255. doi: 10.1002/jmv.1890410314. [DOI] [PubMed] [Google Scholar]
  270. Osmond D. H., Charlebois E., Sheppard H. W., Page K., Winkelstein W., Moss A. R., Reingold A. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis. 1993 Jan;167(1):66–71. doi: 10.1093/infdis/167.1.66. [DOI] [PubMed] [Google Scholar]
  271. Pagliaro L., Craxí A., Cammaá C., Tiné F., Di Marco V., Lo Iacono O., Almasio P. Interferon-alpha for chronic hepatitis C: an analysis of pretreatment clinical predictors of response. Hepatology. 1994 Apr;19(4):820–828. [PubMed] [Google Scholar]
  272. Papo T., Marcellin P., Bernuau J., Durand F., Poynard T., Benhamou J. P. Autoimmune chronic hepatitis exacerbated by alpha-interferon. Ann Intern Med. 1992 Jan 1;116(1):51–53. doi: 10.7326/0003-4819-116-1-51. [DOI] [PubMed] [Google Scholar]
  273. Parés A., Barrera J. M., Caballería J., Ercilla G., Bruguera M., Caballería L., Castillo R., Rodés J. Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology. 1990 Dec;12(6):1295–1299. doi: 10.1002/hep.1840120608. [DOI] [PubMed] [Google Scholar]
  274. Peano G. M., Fenoglio L. M., Menardi G., Balbo R., Marenchino D., Fenoglio S. Heterosexual transmission of hepatitis C virus in family groups without risk factors. BMJ. 1992 Dec 12;305(6867):1473–1474. doi: 10.1136/bmj.305.6867.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  275. Pereira B. J., Milford E. L., Kirkman R. L., Levey A. S. Transmission of hepatitis C virus by organ transplantation. N Engl J Med. 1991 Aug 15;325(7):454–460. doi: 10.1056/NEJM199108153250702. [DOI] [PubMed] [Google Scholar]
  276. Pereira B. J., Milford E. L., Kirkman R. L., Quan S., Sayre K. R., Johnson P. J., Wilber J. C., Levey A. S. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med. 1992 Sep 24;327(13):910–915. doi: 10.1056/NEJM199209243271302. [DOI] [PubMed] [Google Scholar]
  277. Peters T., Mohr L., Scheiffele F., Schlayer H. J., Preisler S., Berthold H., Gerok W., Rasenack J. Antibodies and viremia in acute post-transfusion hepatitis C: a prospective study. J Med Virol. 1994 Apr;42(4):420–427. doi: 10.1002/jmv.1890420416. [DOI] [PubMed] [Google Scholar]
  278. Piperno A., Fargion S., D'Alba R., Roffi L., Fracanzani A. L., Vecchi L., Failla M., Fiorelli G. Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection. J Hepatol. 1992 Nov;16(3):364–368. doi: 10.1016/s0168-8278(05)80671-3. [DOI] [PubMed] [Google Scholar]
  279. Pol S., Driss F., Devergie A., Brechot C., Berthelot P., Gluckman E. Is hepatitis C virus involved in hepatitis-associated aplastic anemia? Ann Intern Med. 1990 Sep 15;113(6):435–437. doi: 10.7326/0003-4819-113-6-435. [DOI] [PubMed] [Google Scholar]
  280. Pol S., Romeo R., Zins B., Driss F., Lebkiri B., Carnot F., Berthelot P., Bréchot C. Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications. Kidney Int. 1993 Nov;44(5):1097–1100. doi: 10.1038/ki.1993.354. [DOI] [PubMed] [Google Scholar]
  281. Pol S., Thiers V., Driss F., Devergie A., Berthelot P., Bréchot C., Gluckman E. Lack of evidence for a role of HCV in hepatitis-associated aplastic anaemia. Br J Haematol. 1993 Dec;85(4):808–810. doi: 10.1111/j.1365-2141.1993.tb03229.x. [DOI] [PubMed] [Google Scholar]
  282. Pontisso P., Ruvoletto M. G., Fattovich G., Chemello L., Gallorini A., Ruol A., Alberti A. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology. 1993 Nov;105(5):1529–1533. doi: 10.1016/0016-5085(93)90161-5. [DOI] [PubMed] [Google Scholar]
  283. Poterucha J. J., Rakela J., Lumeng L., Lee C. H., Taswell H. F., Wiesner R. H. Diagnosis of chronic hepatitis C after liver transplantation by the detection of viral sequences with polymerase chain reaction. Hepatology. 1992 Jan;15(1):42–45. doi: 10.1002/hep.1840150109. [DOI] [PubMed] [Google Scholar]
  284. Prince A. M., Brotman B., Grady G. F., Kuhns W. J., Hazzi C., Levine R. W., Millian S. J. Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. Lancet. 1974 Aug 3;2(7875):241–246. doi: 10.1016/s0140-6736(74)91412-3. [DOI] [PubMed] [Google Scholar]
  285. Prohaska W., Schroeter E., Kaars-Wiele P., Kleesiek K. Enzyme immunoassays for anti-hepatitis C virus antibodies improved specificity and analytical sensitivity by combination of three different recombinant viral proteins in second generation tests. Eur J Clin Chem Clin Biochem. 1992 Jul;30(7):397–404. doi: 10.1515/cclm.1992.30.7.397. [DOI] [PubMed] [Google Scholar]
  286. Prohaska W., Wolff C., Schlüter K., Köster-Eiserfunke W., Körner M. M., Kleesiek K. Immunoglobulin preparations from hepatitis C antibody-positive plasma donors: influence on diagnosis and risk of infection in heart transplant recipients. Clin Investig. 1992 Jul;70(7):573–578. doi: 10.1007/BF00184795. [DOI] [PubMed] [Google Scholar]
  287. Propst T., Propst A., Dietze O., Judmaier G., Braunsteiner H., Vogel W. High prevalence of viral infection in adults with homozygous and heterozygous alpha 1-antitrypsin deficiency and chronic liver disease. Ann Intern Med. 1992 Oct 15;117(8):641–645. doi: 10.7326/0003-4819-117-8-641. [DOI] [PubMed] [Google Scholar]
  288. Protzer U., Ochsendorf F. R., Leopolder-Ochsendorf A., Holtermüller K. H. Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C. Gastroenterology. 1993 Mar;104(3):903–905. doi: 10.1016/0016-5085(93)91029-h. [DOI] [PubMed] [Google Scholar]
  289. Puoti M., Zonaro A., Ravaggi A., Marin M. G., Castelnuovo F., Cariani E. Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus infection. Hepatology. 1992 Oct;16(4):877–881. doi: 10.1002/hep.1840160404. [DOI] [PubMed] [Google Scholar]
  290. Quinti I., Sacco G., el Salman D., Paganelli R., Fiorilli M., Aiuti F., Pandolfi F. Infection with hepatitis C virus. Intravenous gammaglobulin may still infect patients. BMJ. 1994 Mar 26;308(6932):856–856. doi: 10.1136/bmj.308.6932.856a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  291. Ragni M. V., Ndimbie O. K., Rice E. O., Bontempo F. A., Nedjar S. The presence of hepatitis C virus (HCV) antibody in human immunodeficiency virus-positive hemophilic men undergoing HCV "seroreversion". Blood. 1993 Aug 1;82(3):1010–1015. [PubMed] [Google Scholar]
  292. Ralston R., Thudium K., Berger K., Kuo C., Gervase B., Hall J., Selby M., Kuo G., Houghton M., Choo Q. L. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J Virol. 1993 Nov;67(11):6753–6761. doi: 10.1128/jvi.67.11.6753-6761.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  293. Ray R., Khanna A., Lagging L. M., Meyer K., Choo Q. L., Ralston R., Houghton M., Becherer P. R. Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus. J Virol. 1994 Jul;68(7):4420–4426. doi: 10.1128/jvi.68.7.4420-4426.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  294. Read A. E., Donegan E., Lake J., Ferrell L., Galbraith C., Kuramoto I. K., Zeldis J. B., Ascher N. L., Roberts J., Wright T. L. Hepatitis C in patients undergoing liver transplantation. Ann Intern Med. 1991 Feb 15;114(4):282–284. doi: 10.7326/0003-4819-114-4-282. [DOI] [PubMed] [Google Scholar]
  295. Rehermann B., Michitaka K., Durazzo M., Mergener K., Velev P., Manns M. P. Viruses and auto-immune hepatitis. Eur J Clin Invest. 1994 Jan;24(1):11–19. doi: 10.1111/j.1365-2362.1994.tb02053.x. [DOI] [PubMed] [Google Scholar]
  296. Reichard O., Foberg U., Frydén A., Mattsson L., Norkrans G., Sönnerborg A., Wejstål R., Yun Z. B., Weiland O. High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks. Hepatology. 1994 Feb;19(2):280–285. [PubMed] [Google Scholar]
  297. Reichard O., Yun Z. B., Sönnerborg A., Weiland O. Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C. J Med Virol. 1993 Oct;41(2):99–102. doi: 10.1002/jmv.1890410203. [DOI] [PubMed] [Google Scholar]
  298. Reinus J. F., Leikin E. L., Alter H. J., Cheung L., Shindo M., Jett B., Piazza S., Shih J. W. Failure to detect vertical transmission of hepatitis C virus. Ann Intern Med. 1992 Dec 1;117(11):881–886. doi: 10.7326/0003-4819-117-11-881. [DOI] [PubMed] [Google Scholar]
  299. Resnick R. H., Koff R. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance. Arch Intern Med. 1993 Jul 26;153(14):1672–1677. [PubMed] [Google Scholar]
  300. Riezu-Boj J. I., Parker D., Civeira M. P., Phippard D., Corbishley T. P., Camps J., Castilla A., Prieto J. Detection of hepatitis C virus antibodies with new recombinant antigens: assessment in chronic liver diseases. J Hepatol. 1992 Jul;15(3):309–313. doi: 10.1016/0168-8278(92)90061-s. [DOI] [PubMed] [Google Scholar]
  301. Rohr M. S., Lesniewski R. R., Rubin C. A., Johnson R. G., Heise E. R., McDonald J. C., Adams P. L. Risk of liver disease in HCV-seropositive kidney transplant recipients. Ann Surg. 1993 May;217(5):512–517. doi: 10.1097/00000658-199305010-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  302. Romeo R., Thiers V., Driss F., Berthelot P., Nalpas B., Brechot C. Hepatitis C virus RNA in serum of blood donors with or without elevated transaminase levels. Transfusion. 1993 Aug;33(8):629–633. doi: 10.1046/j.1537-2995.1993.33893342742.x. [DOI] [PubMed] [Google Scholar]
  303. Rosman A. S., Paronetto F., Galvin K., Williams R. J., Lieber C. S. Hepatitis C virus antibody in alcoholic patients. Association with the presence of portal and/or lobular hepatitis. Arch Intern Med. 1993 Apr 26;153(8):965–969. [PubMed] [Google Scholar]
  304. Roth D., Fernandez J. A., Babischkin S., De Mattos A., Buck B. E., Quan S., Olson L., Burke G. W., Nery J. R., Esquenazi V. Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission of disease. Ann Intern Med. 1992 Sep 15;117(6):470–475. doi: 10.7326/0003-4819-117-6-470. [DOI] [PubMed] [Google Scholar]
  305. Roth D., Zucker K., Cirocco R., DeMattos A., Burke G. W., Nery J., Esquenazi V., Babischkin S., Miller J. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int. 1994 Jan;45(1):238–244. doi: 10.1038/ki.1994.29. [DOI] [PubMed] [Google Scholar]
  306. Roudot-Thoraval F., Pawlotsky J. M., Thiers V., Deforges L., Girollet P. P., Guillot F., Huraux C., Aumont P., Brechot C., Dhumeaux D. Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: a prospective study with hepatitis C virus RNA testing. Hepatology. 1993 May;17(5):772–777. [PubMed] [Google Scholar]
  307. Sakamoto N., Enomoto N., Kurosaki M., Marumo F., Sato C. Detection and quantification of hepatitis C virus RNA replication in the liver. J Hepatol. 1994 May;20(5):593–597. doi: 10.1016/s0168-8278(05)80345-9. [DOI] [PubMed] [Google Scholar]
  308. Sakamoto N., Enomoto N., Kurosaki M., Marumo F., Sato C. Sequential change of the hypervariable region of the hepatitis C virus genome in acute infection. J Med Virol. 1994 Jan;42(1):103–108. doi: 10.1002/jmv.1890420119. [DOI] [PubMed] [Google Scholar]
  309. Saldanha J., Minor P. A sensitive PCR method for detecting HCV RNA in plasma pools, blood products, and single donations. J Med Virol. 1994 May;43(1):72–76. doi: 10.1002/jmv.1890430114. [DOI] [PubMed] [Google Scholar]
  310. Sallie R., Silva A. E., Purdy M., Smith H., McCaustland K., Tibbs C., Portmann B., Eddleston A., Bradley D., Williams R. Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serological study. J Hepatol. 1994 May;20(5):580–588. doi: 10.1016/s0168-8278(05)80343-5. [DOI] [PubMed] [Google Scholar]
  311. Sansonno D., Dammacco F. Hepatitis C virus c100 antigen in liver tissue from patients with acute and chronic infection. Hepatology. 1993 Aug;18(2):240–245. [PubMed] [Google Scholar]
  312. Santolini E., Migliaccio G., La Monica N. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol. 1994 Jun;68(6):3631–3641. doi: 10.1128/jvi.68.6.3631-3641.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  313. Saracco G., Rosina F., Abate M. L., Chiandussi L., Gallo V., Cerutti E., Di Napoli A., Solinas A., Deplano A., Tocco A. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b. Hepatology. 1993 Dec;18(6):1300–1305. [PubMed] [Google Scholar]
  314. Sato K., Okamoto H., Aihara S., Hoshi Y., Tanaka T., Mishiro S. Demonstration of sugar moiety on the surface of hepatitis C virions recovered from the circulation of infected humans. Virology. 1993 Sep;196(1):354–357. doi: 10.1006/viro.1993.1488. [DOI] [PubMed] [Google Scholar]
  315. Sayers M. H., Gretch D. R. Recombinant immunoblot and polymerase chain reaction testing in volunteer whole blood donors screened by a multi-antigen assay for hepatitis C virus antibodies. Transfusion. 1993 Oct;33(10):809–813. doi: 10.1046/j.1537-2995.1993.331094054616.x. [DOI] [PubMed] [Google Scholar]
  316. Scheuer P. J., Ashrafzadeh P., Sherlock S., Brown D., Dusheiko G. M. The pathology of hepatitis C. Hepatology. 1992 Apr;15(4):567–571. doi: 10.1002/hep.1840150402. [DOI] [PubMed] [Google Scholar]
  317. Schiff E. R. Hepatitis C among health care providers: risk factors and possible prophylaxis. Hepatology. 1992 Nov;16(5):1300–1301. [PubMed] [Google Scholar]
  318. Schirmer M., Vogel W., Thaler J., Grünewald K., Umlauft F., Geisen F., Zilian U., Konwalinka G. Fulminant hepatitis C virus infection. Lancet. 1994 Jun 4;343(8910):1433–1433. doi: 10.1016/s0140-6736(94)92558-5. [DOI] [PubMed] [Google Scholar]
  319. Schupper H., Hayashi P., Scheffel J., Aceituno S., Paglieroni T., Holland P. V., Zeldis J. B. Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C. Hepatology. 1993 Nov;18(5):1055–1060. [PubMed] [Google Scholar]
  320. Schvarcz R., von Sydow M., Weiland O. Autoimmune chronic active hepatitis: changing reactivity for antibodies to hepatitis C virus after immunosuppressive treatment. Scand J Gastroenterol. 1990 Nov;25(11):1175–1180. doi: 10.3109/00365529008998551. [DOI] [PubMed] [Google Scholar]
  321. Seeff L. B., Buskell-Bales Z., Wright E. C., Durako S. J., Alter H. J., Iber F. L., Hollinger F. B., Gitnick G., Knodell R. G., Perrillo R. P. Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med. 1992 Dec 31;327(27):1906–1911. doi: 10.1056/NEJM199212313272703. [DOI] [PubMed] [Google Scholar]
  322. Selby M. J., Choo Q. L., Berger K., Kuo G., Glazer E., Eckart M., Lee C., Chien D., Kuo C., Houghton M. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol. 1993 Jun;74(Pt 6):1103–1113. doi: 10.1099/0022-1317-74-6-1103. [DOI] [PubMed] [Google Scholar]
  323. Shah G., Demetris A. J., Gavaler J. S., Lewis J. H., Todo S., Starzl T. E., Van Thiel D. H. Incidence, prevalence, and clinical course of hepatitis C following liver transplantation. Gastroenterology. 1992 Jul;103(1):323–329. doi: 10.1016/0016-5085(92)91130-v. [DOI] [PMC free article] [PubMed] [Google Scholar]
  324. Sheen I. S., Liaw Y. F., Chu C. M., Pao C. C. Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection. J Infect Dis. 1992 May;165(5):831–834. doi: 10.1093/infdis/165.5.831. [DOI] [PubMed] [Google Scholar]
  325. Sherman K. E., O'Brien J., Gutierrez A. G., Harrison S., Urdea M., Neuwald P., Wilber J. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol. 1993 Oct;31(10):2679–2682. doi: 10.1128/jcm.31.10.2679-2682.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  326. Sheu J. C., Wang J. T., Wang T. H., Wang C. Y., Yang P. M., Huang G. T., Shih L. N., Lee H. S., Chen D. S. Prevalence of hepatitis C viral infection in a community in Taiwan. Detection by synthetic peptide-based assay and polymerase chain reaction. J Hepatol. 1993 Feb;17(2):192–198. doi: 10.1016/s0168-8278(05)80037-6. [DOI] [PubMed] [Google Scholar]
  327. Shev S., Foberg U., Fryden A., Hermodsson S., Lindh G., Lindholm A., Månsson A. S., von Sydow M., Weiland O., Widell A. Second-generation hepatitis C Elisa antibody tests confirmed by the four-antigen recombinant immunoblot assay correlate well with hepatitis C viremia and chronic liver disease in Swedish blood donors. Vox Sang. 1993;65(1):32–37. doi: 10.1111/j.1423-0410.1993.tb04521.x. [DOI] [PubMed] [Google Scholar]
  328. Shih C. M., Lo S. J., Miyamura T., Chen S. Y., Lee Y. H. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol. 1993 Oct;67(10):5823–5832. doi: 10.1128/jvi.67.10.5823-5832.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  329. Shimizu Y. K., Hijikata M., Iwamoto A., Alter H. J., Purcell R. H., Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol. 1994 Mar;68(3):1494–1500. doi: 10.1128/jvi.68.3.1494-1500.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  330. Shimizu Y. K., Weiner A. J., Rosenblatt J., Wong D. C., Shapiro M., Popkin T., Houghton M., Alter H. J., Purcell R. H. Early events in hepatitis C virus infection of chimpanzees. Proc Natl Acad Sci U S A. 1990 Aug;87(16):6441–6444. doi: 10.1073/pnas.87.16.6441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  331. Shindo M., Di Bisceglie A. M., Biswas R., Mihalik K., Feinstone S. M. Hepatitis C virus replication during acute infection in the chimpanzee. J Infect Dis. 1992 Aug;166(2):424–427. doi: 10.1093/infdis/166.2.424. [DOI] [PubMed] [Google Scholar]
  332. Shindo M., Di Bisceglie A. M., Cheung L., Shih J. W., Cristiano K., Feinstone S. M., Hoofnagle J. H. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med. 1991 Nov 1;115(9):700–704. doi: 10.7326/0003-4819-115-9-700. [DOI] [PubMed] [Google Scholar]
  333. Shindo M., Di Bisceglie A. M., Hoofnagle J. H. Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C. Gastroenterology. 1992 Apr;102(4 Pt 1):1406–1408. [PubMed] [Google Scholar]
  334. Shindo M., Di Bisceglie A. M., Hoofnagle J. H. Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon. Hepatology. 1992 Jun;15(6):1013–1016. doi: 10.1002/hep.1840150607. [DOI] [PubMed] [Google Scholar]
  335. Shirai M., Okada H., Nishioka M., Akatsuka T., Wychowski C., Houghten R., Pendleton C. D., Feinstone S. M., Berzofsky J. A. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol. 1994 May;68(5):3334–3342. doi: 10.1128/jvi.68.5.3334-3342.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  336. Sieck J. O., Ellis M. E., Alfurayh O., Ali M. A., Ali H. A., Ayub A., al-Fadda M., Zafar M., Halim M., Bernvil S. S. Histologically advanced chronic hepatitis C treated with recombinant alpha-interferon: a randomized placebo-controlled double-blind cross-over study. J Hepatol. 1993 Nov;19(3):418–423. doi: 10.1016/s0168-8278(05)80552-5. [DOI] [PubMed] [Google Scholar]
  337. Silini E., Bono F., Cerino A., Piazza V., Solcia E., Mondelli M. U. Virological features of hepatitis C virus infection in hemodialysis patients. J Clin Microbiol. 1993 Nov;31(11):2913–2917. doi: 10.1128/jcm.31.11.2913-2917.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  338. Simmonds P., Holmes E. C., Cha T. A., Chan S. W., McOmish F., Irvine B., Beall E., Yap P. L., Kolberg J., Urdea M. S. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993 Nov;74(Pt 11):2391–2399. doi: 10.1099/0022-1317-74-11-2391. [DOI] [PubMed] [Google Scholar]
  339. Simmonds P., Rose K. A., Graham S., Chan S. W., McOmish F., Dow B. C., Follett E. A., Yap P. L., Marsden H. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol. 1993 Jun;31(6):1493–1503. doi: 10.1128/jcm.31.6.1493-1503.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  340. Simmonds P., Smith D. B., McOmish F., Yap P. L., Kolberg J., Urdea M. S., Holmes E. C. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J Gen Virol. 1994 May;75(Pt 5):1053–1061. doi: 10.1099/0022-1317-75-5-1053. [DOI] [PubMed] [Google Scholar]
  341. Simonetti R. G., Cammà C., Fiorello F., Cottone M., Rapicetta M., Marino L., Fiorentino G., Craxì A., Ciccaglione A., Giuseppetti R. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med. 1992 Jan 15;116(2):97–102. doi: 10.7326/0003-4819-116-2-97. [DOI] [PubMed] [Google Scholar]
  342. Sodeyama T., Kiyosawa K., Urushihara A., Matsumoto A., Tanaka E., Furuta S., Akahane Y. Detection of hepatitis C virus markers and hepatitis C virus genomic-RNA after needlestick accidents. Arch Intern Med. 1993 Jul 12;153(13):1565–1572. [PubMed] [Google Scholar]
  343. Sugitani M., Inchauspé G., Shindo M., Prince A. M. Sensitivity of serological assays to identify blood donors with hepatitis C viraemia. Lancet. 1992 Apr 25;339(8800):1018–1019. doi: 10.1016/0140-6736(92)90538-e. [DOI] [PubMed] [Google Scholar]
  344. Suzich J. A., Tamura J. K., Palmer-Hill F., Warrener P., Grakoui A., Rice C. M., Feinstone S. M., Collett M. S. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J Virol. 1993 Oct;67(10):6152–6158. doi: 10.1128/jvi.67.10.6152-6158.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  345. Suzuki E., Kaneko S., Udono T., Tanoue T., Hayashi Y., Yoshihara N., Murakami S., Hattori N., Hayashi M., Sasaoka S. Absence of nonpercutaneous transmission of hepatitis C virus in a colony of chimpanzees. J Med Virol. 1993 Apr;39(4):286–291. doi: 10.1002/jmv.1890390406. [DOI] [PubMed] [Google Scholar]
  346. Sällberg M., Rudén U., Wahren B., Magnius L. O. Immunodominant regions within the hepatitis C virus core and putative matrix proteins. J Clin Microbiol. 1992 Aug;30(8):1989–1994. doi: 10.1128/jcm.30.8.1989-1994.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  347. Takahashi K., Kishimoto S., Yoshizawa H., Okamoto H., Yoshikawa A., Mishiro S. p26 protein and 33-nm particle associated with nucleocapsid of hepatitis C virus recovered from the circulation of infected hosts. Virology. 1992 Nov;191(1):431–434. doi: 10.1016/0042-6822(92)90204-3. [DOI] [PubMed] [Google Scholar]
  348. Takano S., Omata M., Ohto M., Satomura Y. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to HBcAg as a means of preventing posttransfusion hepatitis. Hepatology. 1993 Aug;18(2):235–239. [PubMed] [Google Scholar]
  349. Takehara T., Hayashi N., Mita E., Hagiwara H., Ueda K., Katayama K., Kasahara A., Fusamoto H., Kamada T. Detection of the minus strand of hepatitis C virus RNA by reverse transcription and polymerase chain reaction: implications for hepatitis C virus replication in infected tissue. Hepatology. 1992 Mar;15(3):387–390. doi: 10.1002/hep.1840150305. [DOI] [PubMed] [Google Scholar]
  350. Taniguchi S., Okamoto H., Sakamoto M., Kojima M., Tsuda F., Tanaka T., Munekata E., Muchmore E. E., Peterson D. A., Mishiro S. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology. 1993 Jul;195(1):297–301. doi: 10.1006/viro.1993.1378. [DOI] [PubMed] [Google Scholar]
  351. Terada S., Kawanishi K., Katayama K. Minimal hepatitis C infectivity in semen. Ann Intern Med. 1992 Jul 15;117(2):171–172. doi: 10.7326/0003-4819-117-2-171_2. [DOI] [PubMed] [Google Scholar]
  352. Thaler M. M., Park C. K., Landers D. V., Wara D. W., Houghton M., Veereman-Wauters G., Sweet R. L., Han J. H. Vertical transmission of hepatitis C virus. Lancet. 1991 Jul 6;338(8758):17–18. doi: 10.1016/0140-6736(91)90006-b. [DOI] [PubMed] [Google Scholar]
  353. Thiers V., Lunel F., Valla D., Azar N., Fretz C., Frangeul L., Huraux J. M., Opolon P., Brechot C. Post-transfusional anti-HCV-negative non-A non-B hepatitis (II) serological and polymerase chain reaction analysis for hepatitis C and hepatitis B viruses. J Hepatol. 1993 Apr;18(1):34–39. doi: 10.1016/s0168-8278(05)80007-8. [DOI] [PubMed] [Google Scholar]
  354. Thomas D. L., Factor S. H., Kelen G. D., Washington A. S., Taylor E., Jr, Quinn T. C. Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Arch Intern Med. 1993 Jul 26;153(14):1705–1712. [PubMed] [Google Scholar]
  355. Thornton C. A., Ballow M. Safety of intravenous immunoglobulin. Arch Neurol. 1993 Feb;50(2):135–136. doi: 10.1001/archneur.1993.00540020013009. [DOI] [PubMed] [Google Scholar]
  356. Tibbs C. J., Palmer S. J., Coker R., Clark S. K., Parsons G. M., Hojvat S., Peterson D., Banatvala J. E. Prevalence of hepatitis C in tropical communities: the importance of confirmatory assays. J Med Virol. 1991 Jul;34(3):143–147. doi: 10.1002/jmv.1890340302. [DOI] [PubMed] [Google Scholar]
  357. Tomei L., Failla C., Santolini E., De Francesco R., La Monica N. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol. 1993 Jul;67(7):4017–4026. doi: 10.1128/jvi.67.7.4017-4026.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  358. Tran A., Quaranta J. F., Benzaken S., Thiers V., Chau H. T., Hastier P., Regnier D., Dreyfus G., Pradier C., Sadoul J. L. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology. 1993 Aug;18(2):253–257. [PubMed] [Google Scholar]
  359. Tremolada F., Casarin C., Alberti A., Drago C., Tagger A., Ribero M. L., Realdi G. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol. 1992 Nov;16(3):273–281. doi: 10.1016/s0168-8278(05)80657-9. [DOI] [PubMed] [Google Scholar]
  360. Troisi C. L., Hollinger F. B., Hoots W. K., Contant C., Gill J., Ragni M., Parmley R., Sexauer C., Gomperts E., Buchanan G. A multicenter study of viral hepatitis in a United States hemophilic population. Blood. 1993 Jan 15;81(2):412–418. [PubMed] [Google Scholar]
  361. Tsubota A., Chayama K., Ikeda K., Yasuji A., Koida I., Saitoh S., Hashimoto M., Iwasaki S., Kobayashi M., Hiromitsu K. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology. 1994 May;19(5):1088–1094. [PubMed] [Google Scholar]
  362. Tsukuma H., Hiyama T., Tanaka S., Nakao M., Yabuuchi T., Kitamura T., Nakanishi K., Fujimoto I., Inoue A., Yamazaki H. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993 Jun 24;328(25):1797–1801. doi: 10.1056/NEJM199306243282501. [DOI] [PubMed] [Google Scholar]
  363. Tsutsumi M., Urashima S., Takada A., Date T., Tanaka Y. Detection of antigens related to hepatitis C virus RNA encoding the NS5 region in the livers of patients with chronic type C hepatitis. Hepatology. 1994 Feb;19(2):265–272. [PubMed] [Google Scholar]
  364. Uemura Y., Yokoyama K., Nishida M., Suyama T. Immunoglobulin preparation: safe from virus transmission? Vox Sang. 1989;57(1):1–3. doi: 10.1111/j.1423-0410.1989.tb04974.x. [DOI] [PubMed] [Google Scholar]
  365. Ulmer J. B., Donnelly J. J., Parker S. E., Rhodes G. H., Felgner P. L., Dwarki V. J., Gromkowski S. H., Deck R. R., DeWitt C. M., Friedman A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 1993 Mar 19;259(5102):1745–1749. doi: 10.1126/science.8456302. [DOI] [PubMed] [Google Scholar]
  366. Ulrich P. P., Romeo J. M., Lane P. K., Kelly I., Daniel L. J., Vyas G. N. Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase. J Clin Invest. 1990 Nov;86(5):1609–1614. doi: 10.1172/JCI114882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  367. Van Thiel D. H., Friedlander L., Fagiuoli S., Wright H. I., Irish W., Gavaler J. S. Response to interferon alpha therapy is influenced by the iron content of the liver. J Hepatol. 1994 Mar;20(3):410–415. doi: 10.1016/s0168-8278(94)80017-0. [DOI] [PubMed] [Google Scholar]
  368. Van der Poel C. L., Cuypers H. T., Reesink H. W., Weiner A. J., Quan S., Di Nello R., Van Boven J. J., Winkel I., Mulder-Folkerts D., Exel-Oehlers P. J. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet. 1991 Feb 9;337(8737):317–319. doi: 10.1016/0140-6736(91)90942-i. [DOI] [PubMed] [Google Scholar]
  369. Verbaan H., Andersson K., Eriksson S. Intravenous drug abuse--the major route of hepatitis C virus transmission among alcohol-dependent individuals? Scand J Gastroenterol. 1993 Aug;28(8):714–718. doi: 10.3109/00365529309098279. [DOI] [PubMed] [Google Scholar]
  370. Viladomiu L., Genescà J., Esteban J. I., Allende H., González A., López-Talavera J. C., Esteban R., Guardia J. Interferon-alpha in acute posttransfusion hepatitis C: a randomized, controlled trial. Hepatology. 1992 May;15(5):767–769. doi: 10.1002/hep.1840150504. [DOI] [PubMed] [Google Scholar]
  371. Villa E., Ferretti I., De Palma M., Melegari M., Scaglioni P. P., Trande P., Vecchi C., Fratti N., Manenti F. HCV RNA in serum of asymptomatic blood donors involved in post-transfusion hepatitis (PTH). J Hepatol. 1991 Sep;13(2):256–259. doi: 10.1016/0168-8278(91)90822-s. [DOI] [PubMed] [Google Scholar]
  372. Vincenti F., Lake J., Wright T., Kuo G., Weber P., Stempel C. Nontransmission of hepatitis C from cadaver kidney donors to transplant recipients. Transplantation. 1993 Mar;55(3):674–675. [PubMed] [Google Scholar]
  373. Wang J. T., Sheu J. C., Lin J. T., Wang T. H., Chen D. S. Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells. J Infect Dis. 1992 Nov;166(5):1167–1169. doi: 10.1093/infdis/166.5.1167. [DOI] [PubMed] [Google Scholar]
  374. Wang J. T., Wang T. H., Sheu J. C., Lin J. T., Chen D. S. Hepatitis C virus RNA in saliva of patients with posttransfusion hepatitis and low efficiency of transmission among spouses. J Med Virol. 1992 Jan;36(1):28–31. doi: 10.1002/jmv.1890360106. [DOI] [PubMed] [Google Scholar]
  375. Wang J. T., Wang T. H., Sheu J. C., Lin J. T., Wang C. Y., Chen D. S. Posttransfusion hepatitis revisited by hepatitis C antibody assays and polymerase chain reaction. Gastroenterology. 1992 Aug;103(2):609–616. doi: 10.1016/0016-5085(92)90854-r. [DOI] [PubMed] [Google Scholar]
  376. Wang J. T., Wang T. H., Sheu J. C., Lin S. M., Lin J. T., Chen D. S. Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus. J Clin Microbiol. 1992 Mar;30(3):750–753. doi: 10.1128/jcm.30.3.750-753.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  377. Watanabe J., Matsumoto C., Fujimura K., Shimada T., Yoshizawa H., Okamoto H., Iizuka H., Tango T., Ikeda H., Endo N. Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Japanese experience. Vox Sang. 1993;65(3):199–203. doi: 10.1111/j.1423-0410.1993.tb02148.x. [DOI] [PubMed] [Google Scholar]
  378. Watanabe J., Minegishi K., Mitsumori T., Ishifuji M., Oguchi T., Ueda M., Tokunaga E., Tanaka E., Kiyosawa K., Furuta S. Prevalence of anti-HCV antibody in blood donors in the Tokyo area. Vox Sang. 1990;59(2):86–88. doi: 10.1111/j.1423-0410.1990.tb05015.x. [DOI] [PubMed] [Google Scholar]
  379. Weiner A. J., Geysen H. M., Christopherson C., Hall J. E., Mason T. J., Saracco G., Bonino F., Crawford K., Marion C. D., Crawford K. A. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3468–3472. doi: 10.1073/pnas.89.8.3468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  380. Weiner A. J., Kuo G., Bradley D. W., Bonino F., Saracco G., Lee C., Rosenblatt J., Choo Q. L., Houghton M. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet. 1990 Jan 6;335(8680):1–3. doi: 10.1016/0140-6736(90)90134-q. [DOI] [PubMed] [Google Scholar]
  381. Weiner A. J., Thaler M. M., Crawford K., Ching K., Kansopon J., Chien D. Y., Hall J. E., Hu F., Houghton M. A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants. J Virol. 1993 Jul;67(7):4365–4368. doi: 10.1128/jvi.67.7.4365-4368.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  382. Weinstock H. S., Bolan G., Reingold A. L., Polish L. B. Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. JAMA. 1993 Jan 20;269(3):392–394. [PubMed] [Google Scholar]
  383. Wejstål R., Norkrans G. Chronic non-A, non-B hepatitis in pregnancy: outcome and possible transmission to the offspring. Scand J Infect Dis. 1989;21(5):485–490. doi: 10.3109/00365548909037875. [DOI] [PubMed] [Google Scholar]
  384. Wejstål R., Widell A., Månsson A. S., Hermodsson S., Norkrans G. Mother-to-infant transmission of hepatitis C virus. Ann Intern Med. 1992 Dec 1;117(11):887–890. doi: 10.7326/0003-4819-117-11-887. [DOI] [PubMed] [Google Scholar]
  385. Widell A., Månsson A. S., Sundström G., Hansson B. G., Nordenfelt E. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays. J Med Virol. 1991 Dec;35(4):253–258. doi: 10.1002/jmv.1890350409. [DOI] [PubMed] [Google Scholar]
  386. Willems M., de Jong G., Moshage H., Verresen L., Goubau P., Desmyter J., Yap S. H. Surrogate markers are not useful for identification of HCV carriers in chronic hemodialysis patients. J Med Virol. 1991 Dec;35(4):303–306. doi: 10.1002/jmv.1890350417. [DOI] [PubMed] [Google Scholar]
  387. Williams P. E., Yap P. L., Gillon J., Crawford R. J., Urbaniak S. J., Galea G. Transmission of non-A, non-B hepatitis by pH4-treated intravenous immunoglobulin. Vox Sang. 1989;57(1):15–18. doi: 10.1111/j.1423-0410.1989.tb04977.x. [DOI] [PubMed] [Google Scholar]
  388. Wright T. L. Chronic hepatitis B and C. What is the status of drug therapy? Postgrad Med. 1992 Sep 15;92(4):75–82. doi: 10.1080/00325481.1992.11701466. [DOI] [PubMed] [Google Scholar]
  389. Wright T. L., Donegan E., Hsu H. H., Ferrell L., Lake J. R., Kim M., Combs C., Fennessy S., Roberts J. P., Ascher N. L. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology. 1992 Jul;103(1):317–322. doi: 10.1016/0016-5085(92)91129-r. [DOI] [PubMed] [Google Scholar]
  390. Wright T. L. Hepatitis C virus infection and organ transplantation. Prog Liver Dis. 1993;11:215–230. [PubMed] [Google Scholar]
  391. Wright T. L., Hsu H., Donegan E., Feinstone S., Greenberg H., Read A., Ascher N. L., Roberts J. P., Lake J. R. Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med. 1991 Jul 15;115(2):111–112. doi: 10.7326/0003-4819-115-2-111. [DOI] [PubMed] [Google Scholar]
  392. Wu J. C., Chen C. L., Hou M. C., Chen T. Z., Lee S. D., Lo K. J. Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitations of the polymerase chain reaction. Hepatology. 1994 Apr;19(4):836–840. [PubMed] [Google Scholar]
  393. Yamada M., Kakumu S., Yoshioka K., Higashi Y., Tanaka K., Ishikawa T., Takayanagi M. Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig Dis Sci. 1994 Feb;39(2):234–239. doi: 10.1007/BF02090191. [DOI] [PubMed] [Google Scholar]
  394. Yei S., Yu M. W., Tankersley D. L. Partitioning of hepatitis C virus during Cohn-Oncley fractionation of plasma. Transfusion. 1992 Nov-Dec;32(9):824–828. doi: 10.1046/j.1537-2995.1992.32993110753.x. [DOI] [PubMed] [Google Scholar]
  395. Yoo B. J., Spaete R. R., Geballe A. P., Selby M., Houghton M., Han J. H. 5' end-dependent translation initiation of hepatitis C viral RNA and the presence of putative positive and negative translational control elements within the 5' untranslated region. Virology. 1992 Dec;191(2):889–899. doi: 10.1016/0042-6822(92)90264-p. [DOI] [PubMed] [Google Scholar]
  396. Yoshiba M., Dehara K., Inoue K., Okamoto H., Mayumi M. Contribution of hepatitis C virus to non-A, non-B fulminant hepatitis in Japan. Hepatology. 1994 Apr;19(4):829–835. [PubMed] [Google Scholar]
  397. Yoshioka K., Kakumu S., Wakita T., Ishikawa T., Itoh Y., Takayanagi M., Higashi Y., Shibata M., Morishima T. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology. 1992 Aug;16(2):293–299. doi: 10.1002/hep.1840160203. [DOI] [PubMed] [Google Scholar]
  398. Young K. C., Chang T. T., Liou T. C., Wu H. L. Detection of hepatitis C virus RNA in peripheral blood mononuclear cells and in saliva. J Med Virol. 1993 Sep;41(1):55–60. doi: 10.1002/jmv.1890410112. [DOI] [PubMed] [Google Scholar]
  399. Yuki N., Hayashi N., Hagiwara H., Takehara T., Kasahara A., Fusamoto H., Manabe S., Takamizawa A., Kamada T., Okayama H. HCV RNA and antibody to HCV core protein in Japanese patients with chronic liver disease. Dig Dis Sci. 1992 Oct;37(10):1483–1488. doi: 10.1007/BF01296490. [DOI] [PubMed] [Google Scholar]
  400. Yuki N., Hayashi N., Hagiwara H., Takehara T., Katayama K., Kasahara A., Fusamoto H., Kamada T. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy. Hepatology. 1993 Jun;17(6):960–965. [PubMed] [Google Scholar]
  401. Yun Z. B., Lindh G., Weiland O., Johansson B., Sönnerborg A. Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors. J Med Virol. 1993 Jan;39(1):57–61. doi: 10.1002/jmv.1890390111. [DOI] [PubMed] [Google Scholar]
  402. Zaaijer H. L., Cuypers H. T., Reesink H. W., Winkel I. N., Gerken G., Lelie P. N. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet. 1993 Mar 20;341(8847):722–724. doi: 10.1016/0140-6736(93)90488-3. [DOI] [PubMed] [Google Scholar]
  403. Zaaijer H. L., Mimms L. T., Cuypers H. T., Reesink H. W., van der Poel C. L., Taskar S., Lelie P. N. Variability of IgM response in hepatitis C virus infection. J Med Virol. 1993 Jul;40(3):184–187. doi: 10.1002/jmv.1890400303. [DOI] [PubMed] [Google Scholar]
  404. Zavitsanos X., Hatzakis A., Kaklamani E., Tzonou A., Toupadaki N., Broeksma C., Chrispeels J., Troonen H., Hadziyannis S., Hsieh C. C. Association between hepatitis C virus and hepatocellular carcinoma using assays based on structural and nonstructural hepatitis C virus peptides. Cancer Res. 1992 Oct 1;52(19):5364–5367. [PubMed] [Google Scholar]
  405. Zhang Z. X., Chen M., Wallhagen K., Trojnar J., Magnius L. O., Wahren B., Sällberg M. Molecular basis for antibody cross-reactivity between the hepatitis C virus core protein and the host-derived GOR protein. Clin Exp Immunol. 1994 Jun;96(3):403–409. doi: 10.1111/j.1365-2249.1994.tb06042.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  406. Zignego A. L., Macchia D., Monti M., Thiers V., Mazzetti M., Foschi M., Maggi E., Romagnani S., Gentilini P., Bréchot C. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol. 1992 Jul;15(3):382–386. doi: 10.1016/0168-8278(92)90073-x. [DOI] [PubMed] [Google Scholar]
  407. al-Khaja N., Roberts D. G., Belboul A., Lopere V., Bergman P., Rådberg G., Hermodsson S., Olsson R. G. Gamma globulin prophylaxis to reduce post-transfusion non-A, non-B hepatitis after cardiac surgery with cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg. 1991;25(1):7–12. doi: 10.3109/14017439109098076. [DOI] [PubMed] [Google Scholar]
  408. el-Ashmawy L., Hassanein T., Gavaler J. S., Van Thiel D. H. Prevalence of hepatitis C virus antibody in a liver transplantation population. Dig Dis Sci. 1992 Jul;37(7):1110–1115. doi: 10.1007/BF01300295. [DOI] [PubMed] [Google Scholar]
  409. van Doorn L. J., van Belkum A., Maertens G., Quint W., Kos T., Schellekens H. Hepatitis C virus antibody detection by a line immunoassay and (near) full length genomic RNA detection by a new RNA-capture polymerase chain reaction. J Med Virol. 1992 Dec;38(4):298–304. doi: 10.1002/jmv.1890380413. [DOI] [PubMed] [Google Scholar]
  410. van der Poel C. L., Bresters D., Reesink H. W., Plaisier A. A., Schaasberg W., Leentvaar-Kuypers A., Choo Q. L., Quan S., Polito A., Houghton M. Early antihepatitis C virus response with second-generation C200/C22 ELISA. Vox Sang. 1992;62(4):208–212. doi: 10.1111/j.1423-0410.1992.tb01200.x. [DOI] [PubMed] [Google Scholar]
  411. van der Poel C. L., Reesink H. W., Lelie P. N., Leentvaar-Kuypers A., Choo Q. L., Kuo G., Houghton M. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in The Netherlands. Lancet. 1989 Aug 5;2(8658):297–298. doi: 10.1016/s0140-6736(89)90486-8. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES